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Dendritic cells (DCs) are known to be important immune-regulator in all 
organs, but DCs within the stomach remain poorly characterized. DCs have been 
reported to play a role in regulating host immune responses to Helicobacter 
infection, but the precise role of gastric DCs in gastritis remains unclear. Here, 
gastric DCs were finely characterized and their roles in Helicobacter-induced 
gastritis were investigated. Gastric tissues from DC-deficient mouse models and 
control mice with Helicobacter infection were comparatively analyzed using 
histopathology, flow cytometry, immunohistochemistry or immunofluorescence, 
quantitative real-time PCR and luminex immunoassays. Programmed death ligand 
1 (PD-L1)–deficient mouse models were also used to confirm the T cell regulation 
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mechanism of gastric DCs. The clinical aspects were confirmed by conducting 
multiplexed immunohistochemistry on paraffin-embedded gastric tissue 
microarrays of patients with gastritis. Gastric DCs were composed of 
CD103+CD11b-, CD103-CD11b+, and CD103-CD11b- subsets, and all subsets 
expanded during Helicobacter infection. Helicobacter-infected classical DC-
deficient mice showed severe gastritis and T cell accumulation compared to control 
mice. However, the degree of infiltration of regulatory T cells was not different 
between the two groups. Gastric DCs expressed considerably higher level of PD-
L1 than other immune cells and co-localized with T cells in mouse and human 
stomach. Blockade of PD-L1 exacerbated gastritis with severe T cell accumulation 
during Helicobacter infection. This study indicate that gastric classical DCs 
attenuate Helicobacter-induced gastritis by regulating T cell recruitment through 
PD-L1 expression and that considering the possibility of inflammatory side-effects 
on the stomach would be important when treating cancer patients with PD-L1 
inhibitors. 
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Dendritic cells (DCs) were initially discovered during the preparation of 
adherent mononuclear cells from mouse spleens (Liu and Nussenzweig 2010). DCs 
were recognized as novel cell populations with a characteristic morphology and 
movement, and functional differentiation from other cells, including macrophages 
in the mouse peripheral lymphoid organs (Steinman and Cohn 1973; Steinman and 
Cohn 1974). The “dendritic cell” was named by Ralph Steinman in 1973 due to the 
distinct morphological features (Steinman and Cohn 1973); however, DCs were 
“accessory” cells with a small number in organs, and thus the biological 
significance of DCs was viewed skeptically (Mildner and Jung 2014). Steinman and 
his colleagues showed that DCs are representative antigen-presenting cells that 
initiate antigen-specific cellular immune responses, presenting invaluable evidence 
(Banchereau and Steinman 1998; Mildner and Jung 2014). Immunology had 
focused only on antigens and lymphocytes for some time, and DCs provided 
insights into immune responses that were not adequately explained by only these 
two factors (Banchereau and Steinman 1998).  
Since this discovery, various aspects of DCs, such as functions, development, 
subsets, and migration, have been extensively studied. These studies have been 
carried out in vitro mainly by purifying DCs from mouse spleens or by 
differentiating mouse bone marrow (BM) cells or human monocytes into DCs using 
the granulocyte-macrophage colony-stimulating factor or the fms-like tyrosine 
kinase 3 ligand (Flt3L) (Liu and Nussenzweig 2010). However, DCs are a 
heterogeneous population composed of several subsets and share certain surface 
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markers with immune cells belonging to the mononuclear phagocyte system such 
as macrophages and monocytes, making it difficult to only identify pure DCs 
(Worbs, Hammerschmidt et al. 2017). In addition, several DC-deficient mouse 
models have been used to identify the role of DCs in infectious, autoimmune, and 
metabolic diseases and tumors, but DCs can exhibit various aspects depending on 
the type of disease or the target organs where the lesion occurs. Thus, detailed DCs 
characterization is important in the study of DCs.  
 
Initiation of T cell immunity 
DCs are superior to other immune cells in capturing and processing antigens 
and presenting treated antigen to T cells via the T-cell antigen receptor (TCR) 
(Nussenzweig, Steinman et al. 1980). DCs are indispensable for the stimulation of 
T cells that cannot directly recognize antigens (Banchereau and Steinman 1998). 
DCs present endogenous and exogenous antigens to T cells through the major 
histocompatibility complex (MHC) I and the MHC II, respectively. In addition, 
DCs induce cytotoxic CD8+ T cell immunity by presenting exogenous antigens to 
T cells through MHC I, which is called cross-presentation. Cross-presentation is 
crucial for immunity against viruses and intracellular bacteria (Rock 2003). The 
binding of MHC-peptide complexes on DCs and T cells induces distinct outcomes 
depending on the context of antigens, signals provided by B7 family members on 
DCs and instructing cytokines (Mildner and Jung 2014). In relation to pathogens or 
danger-associated molecular patterns, DCs and T cells can recognize the contexts 
of antigens. In the crosstalk between T cells and DCs, pro-inflammatory T cell 
responses or T cell tolerance is induced depending on the co-stimulatory or co-
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inhibitory signals transmitted by DCs or the maturation state of DCs (Mildner and 
Jung 2014). Thus, DCs play a central role in controlling T cell immunity.  
 
Development and function of DC subsets  
DCs are classified into classical DCs (cDCs), monocyte-derived DCs 
(moDCs), and plasmacytoid DCs (pDCs). They share origins initially in the BM 
and are divided into common-DC progenitors (CDP) and common monocyte 
progenitors (CMoP) according to Flt3L and the macrophage-colony stimulating 
factor (M-CSF) signaling in macrophage-DCs progenitors (MDP). Subsequently, 
cDCs and pDCs are differentiated by fms-like tyrosine kinase 3 (Flt3)-Flt3L 
signaling from CDP, and monocytes and their descendants are differentiated from 
CMoP. cDCs arise from pre-DCs differentiated from CDP in the BM, and the 
differentiated pre-DCs migrate through the blood and are distributed in the 
peripheral organs. pDCs are differentiated from CDP in BM and migrated to 
peripheral organs, and moDCs are differentiated from monocytes in peripheral 
organs (Fig. 1) (Liu and Nussenzweig 2010). 
cDCs are classified into at least two subsets according to the expression of 
CD8α and CD103 or CD11b surface markers. First, CD8α+ cDCs are present in 
lymphoid tissues including the spleen, lymph node and BM. CD103+ cDCs are 
considered to be the same population as CD8α+ cDCs present in non-lymphoid 
tissues (del Rio, Rodriguez-Barbosa et al. 2007; Edelson, KC et al. 2010). CD8α+ 
cDCs and CD103+ cDCs are the most well-characterized cDCs subsets based on 
their phenotypic and gene expression characteristics (Mildner and Jung 2014). 
These CD8α+ and CD103+ cDCs are referred to as the cDC1, and cDC1 is known 
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to be functionally specific for cross-presentation (den Haan, Lehar et al. 2000; 
Bedoui, Whitney et al. 2009). Interferon regulatory factor (IRF) 8, Id2, BATF3, and 
NFIL3 have been reported as transcription factors involved in the development of 
cDC1 lineage (Mildner and Jung 2014). Among them, IRF8 is presumed to be the 
master regulator of cDC1 lineage (Seillet, Jackson et al. 2013). CD11b+ cDCs are 
referred to as cDC2 and are known as heterogeneous populations, unlike CD8α+ 
and CD103+ cDCs. Due to the complexity of this heterogeneity, the characterization 
of CD11b+ cDCs is relatively unclear. RelB, NOTCH2, RBP-J, IRF2, and IRF4 
have been known to regulate CD11b+ cDCs development (Mildner and Jung 2014). 
Of these, IRF4 has also been implicated in the function and migration of CD11b+ 
cDCs (Mildner and Jung 2014). Compared to CD8α+ and CD103+ cDCs, CD11b+ 
cDCs are ineffective for cross-presentation but have been reported to be more 
effective for the induction of CD4+ T cell immunity (Lewis, Caton et al. 2011).  
moDCs also exist in the steady state, but are referred to as “inflammatory DCs” 
because they rapidly aggregate into inflammatory sites (Goudot, Coillard et al. 2017; 
Segura and Amigorena 2013). In addition, tumor necrosis factor (TNF)-inducible 
nitric oxide synthase-producing DCs (TIP DCs) present in pathogen-associated 
inflammation have been considered typical moDCs, but recent studies have 
suggested that TIP DCs correspond to activated effector monocytes rather than to 
DCs (Mildner, Yona et al. 2013). moDCs are difficult to distinguish from CD11b+ 
cDCs because they share surface markers such as CD11c, MHC II, and CD11b, 
with cDCs and can migrate to draining lymph nodes similarly to cDCs to induce 
adaptive immune responses (Liu and Nussenzweig 2010; Chow, Sutherland et al. 
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2017). Detailed studies that explore distinguishing between them would be helpful 
in understanding heterogeneous CD11b+ cDCs.  
pDCs are BM-derived DCs subsets that are rarely found in peripheral blood 
and peripheral organs. Like cDCs, pDCs development is dependent on Flt3-Flt3L 
signaling, and activated pDCs are known to play a role in naive CD4+ T cell priming 
in lymph nodes (Kingston, Schmid et al. 2009; Sapoznikov, Fischer et al. 2007). 
However, they are best known as a population that produces type I interferon in 
response to viral infections, and thus the role of pDCs in innate and adaptive 
immune responses to viral infections has been the subject of many studies (Colonna, 
Trinchieri et al. 2004; Yun, Lee et al. 2016). In addition, the roles of pDCs in 
peripheral and central immune tolerance have been reported in association with 
regulatory T cells (Tregs) induction (Yun, Lee et al. 2016).   
 
Fig 1. Dendritic cell and monocyte origin and development (Liu and 
Nussenzweig 2010)  
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DCs-mediated immune tolerance  
Although DCs induce effective immune response to antigens, they also play 
an important role in maintaining immune tolerance. DCs maintain immune 
tolerance by inducing apoptosis of autoreactive thymocytes and promoting Treg 
differentiation by presenting self-antigens in the thymus (central tolerance). In 
addition, DCs induce anergy, apoptosis of T cells in peripheral organs, and promote 
immune tolerance by promoting Treg response (peripheral tolerance) (Audiger, 
Rahman et al. 2017). Thus, DCs contribute to the balance between immunity and 
tolerance, which is influenced both by various DC factors and by local 
environmental factors that modulate the tolerogenic functions of the DCs.  
Signal transduction through contact between T cells and DCs is an important 
process that determines immunogenic or tolerogenic pathways. The mature state of 
DCs has a significant influence on this signal transmission. Mature DCs, sensing 
pathogens by pattern recognition receptor such as toll-like receptors (TLR) 
(immunogenic maturation), highly express co-stimulatory molecules such as CD80, 
CD86, and CD40, which enhances the efficiency of TCR signaling and promotes 
effector T cell responses. However, immune tolerance is induced when these signals 
are transmitted to Tregs (Yamazaki, Iyoda et al. 2003; Salomon, Lenschow et al. 
2000). On the other hand, DCs matured by self-antigens in steady states 
(homeostatic maturation) and immature DCs expressing low co-stimulatory 
molecules induce immune tolerance (Ardouin, Luche et al. 2016). In addition, DCs 
can induce tolerance by expressing co-inhibitory molecules, canceling stimulatory 
signals that are transmitted to T cells, and delivering inhibitory signals. Among 
these co-inhibitory molecules, programmed death ligand 1 (PD-L1) and 
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programmed death ligand 2 (PD-L2) are well known, and they transmit signals 
through the programmed death 1 (PD-1) expressed in T cells. In addition, the CD86 
and CD80 expressed by DCs can induce T cell tolerance by binding to the cytotoxic 
T lymphocyte–associated antigen 4 (CTLA-4) expressed in T cells (Probst, McCoy 
et al. 2005). 
Specific local environmental factors can also influence the immune tolerance 
role of DCs. DCs present at specific anatomical locations, such as the intestine 
which is continuously exposed to microflora and food antigens, or the skin, are 
known to be suitable for promoting immune tolerance (Audiger, Rahman et al. 
2017). Furthermore, in inflammatory conditions, inflammation-related signals such 
as TLR2, TNF-α, and prostaglandin receptors, and Tregs regulate DCs to perform 
immunoregulatory roles (Popov, Driesen et al. 2008; Darrasse-Jèze, Deroubaix et 
al. 2009).  
The here-described significance of DCs in maintaining immune tolerance has 
been demonstrated to some extent by the phenotype of DC-deficient mouse models, 
and tolerogenic DCs are attracting attention as a potential solution for conditions 
requiring immune tolerance such as autoimmune diseases (Audiger, Rahman et al. 
2017). Thus, studies have been carried out on murine tolerogenic DC subsets and 
their human equivalents (Robbins, Walzer et al. 2008; Guilliams, Dutertre et al. 
2016).  
 
Function of DCs in Helicobacter infection  
It is known that TLR2 and TLR4 play an important role for DCs to recognize 
Helicobacter pylori (H. pylori) and produce cytokines (Rad, Ballhorn et al. 2009). 
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Furthermore, recent studies have shown that CD11b+ gastric DC directly recognize 
and engulf H. pylori in the stomach (Arnold, Zhang et al. 2017).  
Helicobacter-recognizing DCs express maturation markers such as CD80 and 
CD86, and produce pro-inflammatory cytokines such as interleukin (IL)-6, IL-12, 
and IL-23, and activate co-cultured autologous CD4+ T cells to secrete interferon 
gamma (IFN-γ) or IL-17 (Hafsi, Voland et al. 2004; Khamri, Walker et al. 2010). 
Contrary to these pro-inflammatory roles, DCs also play an immune tolerance role 
by inducing Tregs or producing anti-inflammatory cytokines such as IL-10 and 
transforming growth factor (TGF)-β (Rizzuti, Ang et al. 2015; Zhang, Liu et al. 
2010). These in vitro studies were performed using human moDCs or mouse BM-
derived DCs. As described above, DCs have a dual role against Helicobacter. 
In vivo studies to confirm the function of DCs in Helicobacter infection have 
been performed using the CD11c-diphtheria toxin receptor (DTR) which can ablate 
DCs. This study demonstrated the tolerogenic role of DCs against H. pylori (Hitzler, 
Oertli et al. 2011; Oertli, Sundquist et al. 2012), but other CD11c+ cells in addition 
to DCs could also be affected in CD11c-DTR mice (Probst, Tschannen et al. 2005; 
Bennett and Clausen 2007). Therefore, in vivo studies using mouse models that 
ablate DCs only will help identify the role of gastric DCs in Helicobacter infection.  
 
Mouse model of Helicobacter infection 
In the 1980s, Pelayo Correa suggested chronic gastritis as a gastric cancer 
precursor based on clinical and epidemiological observations, proposing sequential 
events leading to the development of gastric adenocarcinoma (Correa 1983; Correa 
1984). Chronic-active gastritis induced by unknown factors progressed to 
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multifocal atrophic gastritis with loss of parietal cells and chief cells, and intestinal 
metaplasia (Sakagami, Dixon et al. 1996). Afterwards, the finding that H. pylori 
was the cause of chronic-active gastritis provided a missing link in the Correa 
pathway (Sakagami, Dixon et al. 1996).  
The only available animal models of H. pylori infection were germ-free piglets 
and non-human primates, and the limited host range of H. pylori has restricted the 
study of the pathogenesis of the disease (Lee, Fox et al. 1990). Although these 
animal models provided important information, the need for a small animal model 
was raised because it was unmanageable, expensive, and only available to a few 
investigators (Lee, O'Rourke et al. 1997). However, early attempts to colonize H. 
pylori on rodents were unsuccessful (Ehlers, Warrelmann et al. 1988; Cantorna and 
Balish 1990). On the other hand, Helicobacter felis (H. felis) isolated from stomach 
of cat was more closely related to H. pylori than any other bacteria based on 16s 
ribosomal RNA sequencing and showed gastric trophism with stable colonization 
in mouse stomach (Lee, Fox et al. 1990). H. felis caused lesions similar to human 
gastric lesions following H. pylori infection in some mouse strains including 
C57BL/6 (Lee, Fox et al. 1990). In particular, C57BL/6 mice showed chronic-active 
gastritis, gastric atrophy, metaplasia as well as dysplasia and gastric cancer after 
12-15 months of infection (Fox et al. 2002).  
Meanwhile, H. pylori isolated from the stomach of patients at the 
gastroenterology clinic in Sydney, Australia, was subsequently colonized stably in 
the stomach of mice through long-term adaptation, which was named the Sydney 
strain 1 (SS1) (Lee, O'Rourke et al. 1997). H. pylori SS1 induced gastric pathology 
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similar to that of H. pylori-infected patients in mice, but could not induce gastric 
cancer (Duckworth, Burkitt et al. 2015).     
 
Objective  
DCs are the central immune cells that regulate innate and adaptive immunity 
in a wide range of pathophysiological conditions. DCs modulate the appropriate 
immune response in various organs while promoting immunity against pathogens 
and maintaining immune tolerance. Based on these important roles, many studies 
have been conducted on the overall characterization of DCs.  
However, gastric DCs are relatively unknown compared to the DCs of other 
organs. In particular, the importance of gastric DCs has been emphasized in 
controlling immunity against H. pylori infection, which is closely related to chronic 
gastritis and gastric cancer in humans. However, in vivo studies to clarify the role 
of gastric DCs in Helicobacter infection are rarely reported. 
In the present study, I tried to characterize gastric DCs. Gastric DCs were 
examined closely in vivo in both steady state and Helicobacter-induced gastritis. 
Furthermore, I tried to identify the major role of gastric DCs in Helicobacter 
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Approximately 50% of the human population is infected by H. pylori. 
However, the host’s immune system cannot eradicate colonized H. pylori in the 
gastric mucosa, causing chronic gastritis. H. pylori-induced chronic gastritis may 
progress to severe gastropathy such as peptic ulcer and gastric cancer. DCs have 
been reported to play an important role in regulating the host immune responses to 
Helicobacter infection, but the precise role of DCs in the stomach remains unclear. 
To investigate the roles of gastric DCs in Helicobacter-induced gastritis, DC-
deficient mice were infected with H. felis and then gastric tissues were analyzed by 
histopathology, flow cytometry, immunohistochemistry, quantitative real-time PCR 
and magnetic luminex immunoassays. It was found that gastric DCs were composed 
of CD103+CD11b-, CD103-CD11b+, and CD103-CD11b- subsets, and all these 
subsets expanded during H. felis infection. H. felis-infected Flt3 knockout (KO) and 
Zbtb46-DTR mice, not BDCA2-DTR mice, showed severe gastric lesions with 
prominent T cell infiltration compared to control group mice. This study indicate 
that gastric cDCs play an important role in suppressing T cell responses during 




H. pylori is a gram negative bacterium that can colonize and survive in the 
human gastric mucosa. Approximately 50% of the human population is colonized 
by H. pylori, and about 15% of them develop severe lesions such as severe chronic 
gastritis, peptic ulcer, gastric adenocarcinoma and lymphoma (Kronsteiner, 
Bassaganya-Riera et al. 2014). H. pylori-induced gastropathy is influenced by 
various factors such as host, bacterial pathogen, and environment-related factors, 
and host’s immune system against H. pylori has been reported to be closely related 
to lesion development (Kusters, van Vliet et al. 2006). 
Various components and products of H. pylori and signals from mucosal 
epithelial cells in contact with H. pylori cause infiltration of innate immune cells 
such as DCs, macrophages, monocytes and neutrophils. Among these innate 
immune cells, DCs have been shown to play an important role in the host T cell 
immune response to H. pylori (Shiu and Blanchard 2013). 
DCs are representative antigen-presenting cells with an exceptional ability to 
modulate the overall immune response to invasive pathogens (Steinman 2012). 
These properties of DCs imply the importance of DCs in the immune responses of 
the gastrointestinal tract, which is constantly exposed to various pathogens. To 
determine the role of DCs in H. pylori infection, many previous studies have 
focused on the direct response of DCs to H. pylori by incubating human moDCs or 
mouse BM-derived DCs with live H. pylori or H. pylori-related proteins in vitro. 
DCs have been shown to recognize H. pylori via pattern recognition receptor such 
as Toll-like receptors (Rad, Ballhorn et al. 2009), and H. pylori-stimulated DCs 
secrete pro-inflammatory cytokines such as IL-6, IL-12 and IL-23 and activate co-
16 
 
cultured autologous CD4+ T cells to secrete IFN-γ or IL-17 (Hafsi, Voland et al. 
2004; Khamri, Walker et al. 2010). In contrast to these pro-inflammatory roles, H. 
pylori-stimulated DCs also play an immune tolerance role by inducing Tregs or 
producing anti-inflammatory cytokines such as IL-10 and TGF-β (Zhang, Liu et al. 
2010; Rizzuti, Ang et al. 2015). As described above, since DCs might have dual 
roles against H. pylori, in vivo studies are highly required to determine the effects 
of DCs on Helicobacter-infected individuals. Several previous in vivo studies used 
the CD11c-DTR mice in which DCs can be ablated and confirmed the tolerogenic 
role of DCs in H. pylori infection (Hitzler, Oertli et al. 2011; Oertli, Sundquist et al. 
2012). However, as macrophages can also be ablated in CD11c-DTR mice, 
elucidating the function of gastric DCs in H. pylori-induced gastritis is difficult 
(Bennett and Clausen 2007). Meanwhile, one study demonstrated that gastric 
CD11b+ DCs engulf H. pylori in gastric mucosa (Arnold, Zhang et al. 2017). 
However, the exact immunological roles of gastric DCs in Helicobacter-induced 
gastritis are largely unknown.  
Many studies on human and animal models of H. pylori infection have 
suggested that CD4+ T cell responses such as helper T cell (Th) 1, Th17, and Tregs 
are predominantly controlled by gastric DCs (Bimczok, Clements et al. 2010; 
Zhang, Liu et al. 2010). However, these CD4+ T cell-mediated immune responses 
were not effective in eradicating the colonized H. pylori in the gastric mucosa, 
rather causing gastritis to become chronic, which is a risk factor for the development 
of peptic ulcer or gastric cancer (Peek, Fiske et al. 2010). Furthermore, CD8+ T cell 
infiltration has been shown to be increased in patients with H. pylori infection, and 
IFN-γ production in response to H. pylori infection is greater in CD8+ T cells than 
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in CD4+ T cells (Bamford, Fan et al. 1998; Quiding-Järbrink, Lundin et al. 2001). 
T cell-mediated IFN-γ improved Helicobacter clearance but contributed to the 
development of severe gastric lesions (Sayi, Kohler et al. 2009). Therefore, CD8+ 
T cell infiltration appear to be closely related to the severity of gastritis and 
Helicobacter clearance, and recent human clinical studies have emphasized the 
potential relevance of CD8+ T cells in the immune response to H. pylori 
(Kronsteiner, Bassaganya-Riera et al. 2014). 
Here gastric DCs were characterized and immune regulatory effect of gastric 
DCs on T cells in Helicobacter-induced gastritis was identified by examining the 
immune responses of Helicobacter-infected DC-deficient mice, including Flt3 KO 
mice, BDCA2-DTR mice, and Zbtb46-DTR mice. Gastric DCs consist of three 
subsets: CD103+CD11b- –, CD103-CD11b+ –, and CD103-CD11b- – DCs. These 
DC subsets were gradually increased during Helicobacter infection. Flt3 KO mice 
showed more severe gastritis with profound infiltration of CD8+ T cells and lower 
bacterial load. Moreover, cDC-ablation increased T cell accumulation in the gastric 
mucosa. These findings indicate that gastric cDCs have a significant impact on the 
T cell immune responses to Helicobacter infection.  
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Materials and Methods 
 
Mice 
Flt3 KO, Zbtb46-DTR, CD11c-EYFP, and BDCA2-DTR mice with C57BL/6J 
background were individually housed in the animal facility of Seoul National 
University or Hanyang University and provided a normal mouse diet and water ad 
libitum. Male C57BL/6J wildtype (WT) mice were purchased from the Japan SLC 
Inc. (Hamamatsu, Shizuoka, Japan) through the Central Lab. Animal Inc. (Seoul, 
Korea). All mice experiments were approved by the Animal Care and Use 
Committees of Seoul National University or Hanyang University (certification 
number: SNU-140320-2-9, HY-IACUC-18-0048). 
 
Bone marrow transplantation 
BM cells from Flt3 KO, Zbtb46-DTR, or BDCA2-DTR mice were injected 
intravenously into lethally irradiated (500 rad twice, 3 hours interval) WT C57BL/6 
mice. BM transplanted mice were fed water containing 7.6% Baytril (Bayer Korea, 
Seoul, Korea) for 2 weeks and monitored about, 6 weeks, until the transplanted BM 
is effectively reconstructed. 
 
Helicobacter culture and Infection 
H. felis (ATCC 49179) was cultured in sterile-filtered brucella broth (Becton 
Dickinson, Sparks, MD, USA) containing 10% FBS. Mouse-adapted H. pylori SS1 
was cultured on brain heart infusion agar plates (Becton Dickinson) containing 10% 
sheep blood and H. pylori Selective Supplement (Thermo Fisher Scientific, 
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Rockford, IL, USA). The brucella broth and brain heart infusion agar plates were 
maintained under microaerobic conditions produced using the GasPakTM EZ 
Campy Container System (Becton Dickinson) at 37°C. The brucella broth was 
maintained at 150 rpm shaking. After 24 hour fasting, 8-week-old mice were orally 
administered 0.2 ml suspension containing 2 × 108 H. felis or 1 × 109 colony-
forming unit/ml H. pylori 4 times every other day. 
 
Diphtheria toxin injection 
The cDCs and pDCs were depleted by intraperitoneally administering 
diphtheria toxin (DT; Calbiochem, San Diego, CA, USA) to Zbtb46-DTR BM 
transplanted mice and BDCA2-DTR BM transplanted mice, respectively. 500 ng 
DT was injected 2 days before H. felis infection. During the infection period, 
Zbtb46-DTR BM transplanted mice were treated with 100 ng DT every 2 days, and 
BDCA2-DTR BM transplanted mice were treated with 200 ng DT every 3 days. 
The control group was treated with PBS instead of DT with the same schedule. 
 
Necropsy and Tissue preparation 
At 2, 4, and 8 weeks after H. felis infection, each group of mice was sacrificed 
together with the non-infected control group, and stomach, gastric lymph node, and 
spleen were removed. The stomach was incised along the greater curvature and 
spread on a filter paper. After cutting the lesser curvature, half of the stomach was 
used for flow cytometry (FACS) and H. felis quantification. The lesser curvature 
portion of the other half was fixed in 10% neutral buffered formalin for 
histopathologic examinations, and the remaining was stored in a -70°C deep freezer 
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for subsequent analysis. At 18 months after H. pylori infection, the H. pylori-
infected groups were treated in the same manner as above. 
 
Histopathologic Examinations 
Gastric tissues fixed in 10% neutral buffered formalin were cut into two strips. 
After standard tissue processing, gastric tissues were embedded in paraffin wax. 
Paraffin sections were stained with haematoxylin and eosin (H&E) and Alcian Blue 
(pH 2.5) stain kit (Vector Laboratories, Burlingame, CA, USA) and performed 
immunohistochemistry (IHC) for H+/K+-adenosine triphosphatase (ATPase) to 
assess histopathological changes. The degree of gastritis and pathological mucosal 
changes were assessed on the basis of previously established updated Sydney 
classification (Chen, van der Hulst et al. 1999; Sayi, Kohler et al. 2009). In the 
sections stained with Alcian Blue, the amount of mucin in the gastric mucosa was 
measured using mean intensity in Image J software (National Institutes of Health, 
Bethesda, MD, USA). In the sections with IHC for H+/K+-ATPase, the number of 
positive cells was manually counted. The mucosa of two different areas was 
examined per slide at ×100 magnification, and the same anatomic areas were 
selected for each sample. 
 
Single-Cell Preparations and Flow Cytometric Analysis  
Gastric single cells were prepared to investigate the type of inflammatory cells 
that infiltrate into the stomach during Helicobacter infection. The gastric tissues 
were incubated in Hank’s balanced salt solution (HBSS) containing 2 mM EDTA 
(Cosmo Genetech, Seoul, Korea), 2% FBS, and 1 mM DL-Dithiothreitol (Sigma-
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Aldrich, St. Louis, MO, USA) for 15 min at 37°C with shaking. Then, the gastric 
tissue was finely trimmed and grinded using gentleMACSTM Dissociator (Miltenyi 
Biotec, Bergisch Gladbach, Germany) and incubated in HBSS containing 100 U/ml 
collagenase D (Roche, Mannheim, Germany), 10% FBS, and 10 mM HEPES for 
30 min at 37°C with shaking. After incubation, the gastric tissue was grinded once 
more using the gentleMACSTM Dissociator, filtered through a 70 μm cell strainer, 
and centrifuged to collect the separated single cells. Finally, the single cells were 
prepared by combining the cells collected from the suspension and from the gastric 
tissue. The gastric lymph node and spleen were incubated with 400 U/ml 
collagenase D at 37°C for 20 min to obtain separated single cells. The prepared 
single cells were primarily stained with Zombie Aqua (BioLegend, San Diego, CA, 
USA) to discriminate dead cells as per manufacturer’s protocol. Zombie aqua 
stained cells were then processed for Fc receptor block by using TruStain FcX 
antibody (anti-CD16/32, clone 93, BioLegend), to avoid non-specific binding. After 
the Fc receptors block, cells were incubated with a mixture of fluorochrome-
labelled antibodies at 4°C for 30 min. To stain transcription factors (Foxp3, IRF4, 
IRF8 and Zbtb46), cells were fixed and permeabilized with Foxp3/Transcription 
Factor Staining Buffer Set (Thermo Fisher Scientific), as per manufacturer’s 
protocol, and then stained with antibody against each transcription factor. After 
washing briefly with RPMI 1640 medium with 10% FBS, cells were analyzed using 
BD LSRFortessa (BD Biosciences, San Jose, CA, USA) and FlowJo software 





Antibodies for flow cytometry 
The antibodies used for FACS are listed in Table 1. 
Table 1. List of antibodies 
Antibody Clone Catalog No. Source 
CD103 2E7 11-1031-81 eBioscience 
Foxp3 FJK-16s 17-5773-82 eBioscience 
IRF8 V3GYWCH 17-9852 eBioscience 
Siglec-H eBio440c 48-0333-80 eBioscience 
CD4 GK1.5 553730 
BD 
Bioscience 
Zbtb46 U4-1374 565832 
BD 
Bioscience 




101206, 101216, 101212, 
101226 
BioLegend 
CD64 X54-5/7.1 139304, 149320 BioLegend 
MHC II M5/114.15.2 107621, 107628 BioLegend 
Ly6C HK1.4 128006 BioLegend 
CD45 30-F11 103130 BioLegend 
CD11c N418 117318 BioLegend 
NK1.1 PK136 108714 BioLegend 
CD8α 53-6.7 100762 BioLegend 
F4/80 BM8 123146 BioLegend 
IRF4 IRF4.3E4 646408 BioLegend 
PDCA-1 927 127015 BioLegend 
CD19 6D5 115527 BioLegend 
B220 RA3-6B2 103223 BioLegend 
CD3 17A2 100228 BioLegend 
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Ly6G 1A8 127641 BioLegend 
XCR1 ZET 148220 BioLegend 
Rat IgG2α, κ 
Isotype 
RTK2758 




Immunohistochemistry and Immunofluorescence 
After paraffin-embedded sections were dewaxed and hydrated, antigen 
retrieval was performed using citrate buffer (pH 6.0; Sigma-Aldrich). Next, the 
sections were incubated with 0.3% hydrogen peroxide solution for 30 min to block 
endogenous peroxidase activity. The ImmPRESS Peroxidase Polymer kit (Vector 
Laboratories) was used according to manufacturer’s protocol. Briefly, paraffin-
embedded sections were blocked with 2.5% normal horse serum or 2.5% normal 
goat serum for 1 hour and then incubated with the following primary antibodies at 
4°C overnight or at 20°C for 2 hours: rabbit anti-CD3 (1:200; Dako, Glostrup, 
Denmark), rabbit anti-CD11c (1:400; Cell Signaling Technology, Danver, MA, 
USA), and mouse anti-ATPase (1:4000; MBL, Woburn, MA, USA). The paraffin-
embedded sections were washed with PBS and then incubated with appropriate 
horseradish peroxidase-conjugated secondary antibody (Vector Laboratories) for 1 
hour. ImmPACT DAB substrate (Vector Laboratories) was used for chromogenic 
detection. The sections were counterstained with hematoxylin. In anti-ATPase IHC, 
Mouse on Mouse ImmPRESS Peroxidase Polymer Kit (Vector Laboratories) was 
used to block endogenous mouse immunoglobulin.  
For frozen sections of CD11c-EYFP mice, the sections were counterstained 
with DAPI and mounted using mounting medium (Vector Laboratories). The 
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images were obtained using confocal fluorescence microscope (Eclipse TE200; 
Nikon, Japan). 
 
H. felis Quantification 
Total DNA was extracted from the gastric tissues (corpus and antrum) by using 
QIAamp DNA mini kit (Qiagen, Hilden, Germany) and used to identify H. felis 
DNA. Quantitative real-time PCR (qRT-PCR) was performed using specific 
primers for H. felis flagellar filament B (Fla-B), Rotor-Gene SYBR Green PCR kit, 
and Rotor-Gene Q (Qiagen). The amplified target DNA was analyzed using Rotor-
Gene Q series software. The H. felis Fla-B primer–F: 5′-TTC GAT TGG TCC TAC 
AGG CTC AGA-3′ and R: 5′-TTC TTG TTG ATG ACA TTG ACC AAC GCA-3′– 
was used (El-Zaatari, Kao et al. 2013). Next, the Warthin-Starry Stain Kit (Abcam) 
was used to identify the location of H. felis and to assess the extent of colonization 
in the stomach. Colonized H. felis were counted manually from two sections of each 
gastric tissue. 
 
Quatitative Reverse Transcription-PCR 
Total RNA from gastric tissues was extracted using Hybrid-R RNA 
purification kit (GeneAll, Seoul, Korea). The cDNA was synthesized from 0.1 μg 
of RNA by using QuantiTect Reverse Transcription kit (Qiagen). qRT-PCR was 
performed using specific primers, Rotor-Gene SYBR Green PCR kit, and Rotor-
Gene Q (Qiagen). The amplified target cDNA was analyzed using Rotor-Gene Q 
series software against the housekeeping gene GAPDH. The specific primer pairs 
were F: 5′-TGC ACC ACC AAC TGC TTA G-3′ and R: 5′-GGA TGC AGG GAT 
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GAT GTT C-3′ for mouse GAPDH; F: 5′-AGC GGC TGA CTG AAC TCA GAT 
TGT AG-3′ and R: 5′-GTC ACA GTT TTC AGC TGT ATA GGG-3′ for mouse IFN-
γ; F: 5′-GCT CCA AGA CCA AGG TGT CT-3′ and R: 5′-CTA GGT CCT GGA 
GTC CAG CA-3′ for mouse IL-10; and F: 5′-CTT CAA TAC GTC AGA CAT TCG 
GG-3′ and R: 5′-GTA ACG CCA GGA ATT GTT GCT A-3′ for mouse TGF-β. 
Primers for mouse Granzyme A (cat. QT01551690) and perforin (cat. QT00282002) 
were purchased from Qiagen QuantiTect Primer Assay (Qiagen). 
 
Magnetic Luminex immunoassay 
For protein extraction, gastric tissues of H. felis-infected and non-infected WT 
and Flt3 KO mice were lysed using Cell Lysis Buffer 2 (R&D systems, Minneapolis, 
MN, USA). Chemokine and cytokine protein concentrations were measured using 
Mouse Premixed Multi-Analyte Kit (cat. LXSAMSM; R&D systems,) according to 
the manufacturer protocol. 
 
Statistical Analysis 
All data are shown as means ± standard errors. Statistical analysis was 
performed using GraphPad Prism 7.00 (GraphPad Software, San Diego, CA, USA). 
Two groups were compared using Mann-Whitney U test or unpaired t-test with two-
tailed distributions. When three or more groups were included, the results were 
analyzed using Kruskal-Wallis test or ordinary one-way ANOVA followed by 
Mann-Whitney U test or unpaired t-test with two-tailed distributions. Meanwhile, 
Pearson’s correlation coefficient was used to determine statistical dependence of H. 
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Gastric DCs have three distinct subpopulations 
To characterize gastric DCs, CD45+ leukocytes were gated out from live cells 
and neutrophils (Ly6G+CD11b+), eosinophils (Siglec F+CD11b+), and macrophages 
(CD64+CD11b+) were sequentially excluded from the CD45+ cells. Next, gastric 
DCs were defined as CD64-CD11c+MHC II+ cells and their levels of CD103 and 
CD11b expression were further analyzed (Fig 1A). Under normal condition, the 
gastric CD64-CD11c+MHC II+ cells occupied about 0.24% of the total live single 
cells and were composed of three subsets including CD103+CD11b- (17.9%), 
CD103-CD11b+ (45.3%), and CD103-CD11b- (double-negative, DN; 32.1%) 
populations (Fig 1A and 2A).  
To confirm that these subsets are DCs, the level of surface marker expression 
of each subset was measured by FACS analysis. The expression of Zbtb46, which 
is expressed specifically in human and murine cDCs (Reizis 2012; Satpathy, KC et 
al. 2012), was higher in all subsets, especially in the CD103+ subset, than in the 
isotype control. The expression of IRF4 and IRF8 was significantly higher in the 
CD11b+ and CD103+ subsets than in the isotype control. The DN subset also 
showed higher levels of IRF4 and IRF8 than those in the isotype control. The 
transcription factors IRF4 and IRF8 regulate CD11b+ and CD103+ cDC 
development, respectively (Mildner and Jung 2014). Among the known 
transcription factors involved in CD103+ cDC development, IRF8 appears to be the 
most important factor (Seillet, Jackson et al. 2013). The expression of XCR1, a 
potential marker for human and mouse CD103+ DCs (Bachem, Güttler et al. 2010), 
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was higher in all DC subsets than in the isotype control and was more prominent in 
the CD103+ subset (Fig 1B).  
To further confirm that the CD64-CD11c+MHC II+ cells are DCs, the stomachs 
of Flt3 KO mice deficient in peripheral DCs were examined. Flt3 is an important 
regulator of DC homeostasis at the periphery, and only cDCs and pDCs are deficient 
in peripheral lymphoid organs of Flt3 KO mice (Waskow, Liu et al. 2008). Further, 
as the non-lymphoid tissues of Flt3 KO mice, the aorta have fewer cDCs and pDCs 
(Choi, Cheong et al. 2011; Yun, Lee et al. 2016). The number of CD64-
CD11c+MHC II+ cells and CD103+, CD11b+, and DN subsets was markedly lower 
in the stomach of Flt3 KO mice than in that of WT mice (Fig 1C). To confirm the 
location of DCs in the normal mouse stomach, immunostaining of CD11c was 
performed and the gastric tissues of normal CD11c-EYFP mice were observed by 
confocal microscopy. The CD11c+ cells were very few and were mainly located in 
the superficial layer of the mucosal lamina propria and were well observed around 





































































































































































































Fig 1. Characterization of gastric DCs. (A) Gating strategy to identify DCs and DC 
subsets from isolated cells of entire glandular stomach. (B) Distinctive marker 
expression of DC subsets. CD103+ DCs are IRF8+XCRhigh, CD11b+ DCs are 
IRF4+XCRlow, and CD103-CD11b- DCs show mixed expression profile of these 
markers. Note that all DC subsets express Zbtb46. (C) The percentage of DCs and 
DC subsets in the live single cells of the stomach in the normal Flt3 KO and WT 
mice. Representative FACS plots (left panel). Gastric DCs and all DC subsets are 
deficient in Flt3 KO mice (n=9) compared to WT mice (n=11). (*P < 0.01 and **P 
< 0.001) (D) Localization of gastric CD11c+ DCs (arrows) under the steady state. 
Top panel: Representative images of CD11c IHC (DAB). Bottom panel: 
Representative images of normal CD11c-EYFP mouse stomach. The asterisk 
indicates a limiting ridge that is the boundary of the glandular and nonglandular 
stomach. (Lu: lumen, M.S: mucosal surface, Mu: mucosa, S.M: submucosa, M.E: 













Helicobacter infection increased the number of DCs in the stomach 
To investigate the role of DCs in gastritis, changes of gastric DCs in H. felis-
infected WT mice were examined by sequential autopsy at 2, 4, and 8 weeks after 
infection. FACS analysis showed that, with an increase in the duration of H. felis 
infection, the infiltration of leukocytes and DCs into the stomach increased. During 
2 to 8 weeks of H. felis infection, infiltration of CD45+ leukocytes and CD64-
CD11c+MHC II+ DCs into the stomach was more apparent than that under steady 
state, approximately 1.8 to 2.8 fold and 2.1 to 4.2 fold, respectively, based on the 
ratio of single cells. Furthermore, the CD103+ and DN subsets increased markedly 
at 2, 4, and 8 weeks after H. felis infection, and the CD11b+ subset increased 
significantly at 4 and 8 weeks after H. felis infection (Fig 2A). To observe the 
changes in the distribution and number of DCs in the stomach, immunostaining of 
CD11c was performed. CD11c+ cells were mainly located in the inflamed 
submucosa and mucosal laminar propria right above the muscularis mucosa, and a 
few were distributed throughout the mucosal lamina propria. The number of 
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Fig 2. Numerical increase and location of gastric DCs during H. felis infection. (A) 
The percentage of leukocytes, DCs, and DC subsets in the live single cells of the 
stomach in the WT mice with H. felis infection. Top panel: Representative FACS 
plots. Bottom panel: Asterisks at 2, 4, and 8 weeks after H. felis infection (n=13-14 
for each group) signify significant increase compared to that in normal WT mice 
(n=11). (B) Localization of CD11c+ DCs (arrows) in H. felis infected WT mouse 
stomach. Top: CD11c IHC (DAB). Bottom: Manual cell count number of CD11c+ 
DCs in 2 paraffin sections (n=5 for each group) (*P < 0.01, **P < 0.001, and ***P 










Flt3 KO mice have more severe gastric inflammation with less Helicobacter 
colonization 
To determine the role of DCs in Helicobacter-induced gastritis, whether the 
immune responses differed between H. felis-infected Flt3 KO and WT mice was 
investigated. First, the severity of gastritis between the two groups was compared 
at 2, 4, and 8 weeks after H. felis infection. Histologically, inflammation occurred 
mainly in the corpus. In the WT mice, infiltration of neutrophils into the submucosa 
was mainly observed after 2 weeks of infection, and infiltration of lymphocytes and 
plasma cells as well was noted at 4 weeks and the most prominently at 8 weeks after 
infection. These inflammatory cells mostly infiltrated into the submucosa, and, as 
the severity of gastritis increased, they infiltrated into the mucosal lamina propria. 
In addition, lymphoid follicles were occasionally present in the submucosa or 
mucosa. In contrast, in Flt3 KO mice, infiltration of not only neutrophils but also 
many lymphocytes and plasma cells was noted at 2 weeks and continued to increase 
gradually until 8 weeks. The infiltration of inflammatory cells was mainly observed 
in the submucosa, but often diffusely expanded to the entire mucosal lamina propria. 
Therefore, gastritis was more marked in Flt3 KO mice than in WT mice (Fig 3A). 
In the corpus mucosa of mice in which inflammation had spread to the mucosa, 
varying numbers of parietal cells were lost and replaced by foveolar cell and 
mucous neck cell hyperplasia. In addition, some mature chief cells 
transdifferentiated to the metaplastic mucous-secreting cells, which appears to be a 
process of spasmolytic polypeptide-expressing metaplasia (SPEM) (Weis, Sousa et 
al. 2013). The degree of loss of parietal cells was confirmed by IHC for H+/K+ 
ATPase and the degree of mucous neck cell hyperplasia and transdifferentiation of 
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chief cells was confirmed by Alcian blue staining (Fig 3B). The mucosal changes 
were more prominent in Flt3 KO mice, which have more severe gastritis, than in 
WT mice (Fig 3C). Furthermore, in H. pylori infection, gastritis tended to be more 
severe in Flt3 KO mice than in WT mice. According to the updated Sydney 
classification, inflammation scores were 2 ± 1 in Flt3 KO mice and 1 or 2 in WT 
mice (Fig 3D).  
Many previous studies have shown a strong positive correlation between the 
degree of inflammation and clearance of infectious agents. The clearance of 
Helicobacter in the stomach has been reported to be dependent on CD4+ T cell-
mediated IFN-γ (Sayi, Kohler et al. 2009). Therefore, the degree of H. felis 
colonization in each group was measured. H. felis was mainly present in the gastric 
pits and mucus layer throughout the glandular part (Fig 3E). The degree of H. felis 
colonization increased during 8 weeks of infection. Bacterial load was lower in Flt3 
KO mice than in WT mice, and this difference was the most noticeable after 8 weeks 
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Fig 3. Deterioration of Helicobacter-induced gastric lesions and decrease of 
bacterial load in Flt3 KO mice (A) Histopathological analysis of H. felis-induced 
gastritis. H&E stained representative images of WT (left panel) and Flt3 KO (right 
panel) mice were aligned. (B) Histopathological analysis of H. felis-induced 
oxyntic atrophy and mucous metaplasia. Representative serial images of WT (left 
panel) and Flt3 KO (right panel) mice subjected to Alcian blue staining (top) and  
H+/K+-ATPase IHC (bottom) were aligned. (2, 4, and 8 weeks after H. felis 
infection). (C) Top: Inflammation score. Each mouse was scored (n=13-17 for each 
group). Middle and Bottom: Mean intensity of mucosal Alcian blue positive and 
manual cell count number of H+/K+-ATPase+ cells (parietal cells), respectively 
(n=10 for each group). (D) Histopathological analysis of H. pylori-induced gastritis. 
H&E stained representative sections of H. pylori-infected WT (left panel) and Flt3 
KO (right panel) mice (WT–n=7; Flt3 KO–n=5) (E) Localization of H. felis (white 
arrowheads) in WT and Flt3 KO mouse stomach (Warthin-Starry stain). (F) Manual 
count number of H. felis in 2 paraffin sections (n=4-7 for each group). (G) H. felis 
loads were evaluated using qRT-PCR for H. felis Fla-B DNA extracted from the 
corpus and antrum (n=7-10 for each group). (*P < 0.05 and **P < 0.01) Weeks: 













Flt3 KO mice showed more prominent CD8+ T cell accumulation than WT mice 
during Helicobacter infection 
FACS analysis was used to observe the changes in various leukocyte 
populations that infiltrated into H. felis-infected stomach (Fig 4). Among the 
leukocyte populations, T cell infiltration was the most prominent difference 
between WT and Flt3 KO mice. In Flt3 KO mice, infiltration of CD8+ T cell was 
dramatically higher than that in WT mice. In addition, infiltration of CD4+ T cell 
tended to be greater in Flt3 KO mice than in WT mice when the H. felis infection 
persisted for 8 weeks. However, no difference in the extent of Treg infiltration was 
noted between the two groups (Fig 5A). These phenotypes were recapitulated in the 
H. pylori-infected Flt3 KO mice (Fig 5B). The T cell infiltration was more 
prominent in not only submucosa but also mucosal lamina propria in Flt3 KO mice 
than in WT mice (Fig 5C). Meanwhile, in the gastric lymph node and spleen, the 
degree of T cell accumulation was not different between the two groups (Fig 5D 
and 5E). To confirm a clear correlation between infiltrated immune cells and H. 
felis clearance, the degree of infiltration of each leukocyte population and H. felis 
loads were compared in each H. felis-infected mouse. As the result, CD8+ and CD4+ 
T cells seemed to have the major effect on bacterial clearance (Fig 5F). H. felis 
infection increased the mRNA expression of various cytokines related to 
inflammation. The expression of IFN-γ was significantly higher by approximately 
6 fold in Flt3 KO mice than in WT mice. In addition, granzyme A and perforin, 
which are closely related to CD8+ T cell activity, were approximately 2.9 and 2.2 
fold higher in Flt3 KO mice than in WT mice, respectively. On the other hand, no 
significant difference in IL-10 and TGF-β was observed between the two groups 
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(Fig 5G). The levels of various chemokines, including CCL2 (MCP-1), CCL3 
(MIP-1α), CCL4 (MIP-1β), CCL5 (RANTES), and CCL8 (MCP-2), were higher in 
the gastric tissue of H. felis-infected Flt3 KO mice than in that of WT mice. The 
difference between the two groups was clearly observed after 8 weeks of H. felis 
infection (Fig 5H). The abovementioned chemokines belong to the C-C chemokine 
family, which has chemotactic effect mainly on monocytes and lymphocytes 
(Yamaoka, Kita et al. 1998), and are particularly well known for promoting T cell 
induction (Roth, Carr et al. 1995). CCL2, CCL3, CCL4, and CCL5 are produced in 
activated CD8+ T cells, and CCL2 and CCL5 contribute to T cell migration to the 
peripheral infection site (Kim, Nottingham et al. 1998; Ohtani, Ohtani et al. 2004). 
These data indicate DC ablation increased pro-inflammatory chemokines which 



































Fig 4. Gating strategy to identify various types of immune cells from isolated cells 
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Fig 5. Prominent CD8+ T cell response of H. felis-infected Flt3 KO mice. (A) The 
percentage of CD8+ and CD4+ T cells and Tregs in the live single cells of the 
stomach in the Flt3 KO and WT mice with H. felis infection (n=13-17 for each H. 
felis infection group, n=9-11 for the non-infection group). Representative FACS 
plots (top panel). (B) As in (A), but with H. pylori infection (WT–n=7; Flt3 KO–
n=5). Note that CD8+ T cells are higher in Flt3 KO mice. (C) More severe mucosal 
infiltration of T cells in the stomach of Flt3 KO mice. Representative images of 
CD3 IHC (DAB). (D) T cell accumulation in the gastric lymph node (LN) and 
spleen of WT and Flt3 KO mice after H. felis infection for 8 weeks. The percentage 
of total, CD8+, and CD4+ T cells, and Tregs in the live single cells of the gastric LN 
and spleen. Note that DC depletion did not affect the T cell ratio in single cells in 
gastric LN and spleen. (gastric LN: WT–n=9; Flt3 KO–n=10, spleen: WT–n=10; 
Flt3 KO–n=9) (E) Correlation between the severity of T cell infiltration and H. felis 
bacterial clearance in the stomach. A total of 51 WT and Flt3 KO mice infected with 
H. felis for 2 to 8 weeks were plotted against the percentage of CD8+ T cells and 
CD4+ T cells in the live single cells of the stomach and the number of H. felis. Note 
that H. felis-induced CD8+ and CD4+ T cell responses are negatively correlated with 
H. felis bacterial loads (P < 0.0001 and P = 0.0012) (F) Relative gastric mRNA 
expression level of inflammatory cytokines. Results are shown as fold change 
compared with that in the non-infection group. (n=6-7 for H. felis infection group, 
n=2-3 for the non-infection group). (G) Analysis of gastric chemokine levels of H. 
felis-infected Flt3 KO and WT mice by using magnetic luminex immunoassay. The 
measured protein concentrations (pg/ml) were corrected for the total protein content 
(mg/ml). (n=7 and 9 for group with 4 and 8 weeks of H. felis infection; n=5 for non-









Enhanced gastric inflammation of Helicobacter-infected Flt3 KO mice was 
hematopoietic cell-intrinsic 
To determine whether the H. felis-induced immune response in Flt3 KO mice 
was hematopoietic cell-intrinsic, BM chimeras were created by transplantation Flt3 
KO or WT BM into irradiated WT mice. The H. felis-infected recipient mice were 
analyzed after 8 weeks. FACS analysis of the gastric tissues showed that all subsets 
of gastric DCs were significantly decreased in the Flt3 KO BM transplanted mice, 
compared with WT BM transplanted mice (Fig 6A). The CD8+ and CD4+ T cell 
response was more prominent in Flt3 KO BM transplanted mice than in WT BM 
transplanted mice. There was no difference in the degree of infiltration of Tregs 
between the two groups (Fig 6B). The bacterial load in the stomach was lower in 







































Fig 6. Prominent CD8+ T cell response and decrease of bacterial load in H. felis-
infected Flt3 KO BMTed mice after H. felis infection for 8 weeks. (A) The 
percentage of DCs and DC subsets in the live single cells of the stomach in the Flt3 
KO BMTed (n=8) and WT BMTed (n=9) mice. Representative FACS plots (left 
panel). (B) The percentage of CD8+ and CD4+ T cells and Tregs in the live single 
cells of the stomach in the Flt3 KO BMTed (n=8) and WT BMTed (n=9) mice. 
Representative FACS plots (top panel). (C) H. felis loads were evaluated using qRT-
PCR for H. felis Fla-B DNA extracted from corpus and antrum. (WT BMTed–n=9; 




Depletion of cDCs enhanced Helicobacter-induced gastric inflammation 
Since Flt3 KO mice lack pDCs as well as cDCs, the involvement of pDCs in 
the suppression of T cell response to H. felis could not be ruled out. Therefore, I 
attempted to elucidate the function of Flt3-dependent cDCs and pDCs on the 
immune response to H. felis infection by using Zbtb46-DTR mice and BDCA2-
DTR mice, in which only cDC and pDC ablation is noted, respectively. DT injection 
has been shown to be lethal to Zbtb46-DTR mice within 1–2 days (Rombouts, 
Cools et al. 2017). In BDCA2-DTR mice, BM transplantation can lead to long-term 
depletion of pDCs (Yun, Lee et al. 2016). Thus, BM of Zbtb46-DTR and BDCA2-
DTR mice was transplanted into irradiated WT mice. Gastric DCs were effectively 
ablated by DT injection in Zbtb46-DTR BM transplanted mice (Fig 7A). Among 
the other leukocyte populations, both CD4+ and CD8+ T cell responses were more 
prominent in cDC-ablated mice. However, gastric Tregs were not affected by cDC 
depletion (Fig 7B). Histologically, cDC ablation produced more severe 
inflammation and pathological mucosal changes (Fig 7C, 7D, and 7E). The 
expression of IFN-γ mRNA in the gastric tissues was markedly increased in cDC-
ablated mice (Fig 7F).  
Meanwhile, gastric pDCs were defined as CD64-CD11b-
Ly6ChiPDCA1+B220+Siglec H+ population (Fig 8A). The pDCs were effectively 
ablated by DT injection in BDCA2-DTR BM transplanted mice (Fig 8B). However, 
no differences in T cell accumulation in the stomach were noted between pDC-
ablated mice and control mice (Fig 8C). Taken together, these results indicate that 


































































Fig 7. Deterioration of H. felis-induced gastric lesions and prominent T cell 
response in DT-injected Zbtb46-DTR BMTed mice (cDC-ablated mice) after H. 
felis infection for 4 weeks. (A) The percentage of DCs and DC subsets in the live 
single cells of the stomach in the cDC-ablated mice (n=10) and PBS-injected 
Zbtb46-DTR BMTed mice (control mice; n=8). Representative FACS plots (left 
panel). Note that gastric DCs and DC subsets are Zbtb46-dependent cDCs. (B) The 
percentage of total, CD8+, and CD4+ T cells, and Tregs in the live single cells of the 
stomach in the cDC-ablated (n=10) and control (n=8) mice. Representative FACS 
plots (left panel). Note that cDC depletion did not affect the Tregs ratio in single 
cells. (C) Histopathological analysis of H. felis-induced gastritis. H&E stained 
representative images of control (left panel) and cDC-ablated (right panel) mice. 
(D) Histopathological analysis of H. felis-induced oxyntic atrophy and mucous 
metaplasia. Representative serial images of control (left panel) and cDC-ablated 
(right panel) mice subjected to Alcian blue staining (top) and  H+/K+-ATPase IHC 
(bottom). (E) Left: Inflammation score, Middle: Mean intensity of mucosal Alcian 
blue positive, Right: Manual cell count number of H+/K+-ATPase+ cells (parietal 
cells) (control mice–n=8; cDC-ablated mice–n=10) (F) Relative gastric mRNA 
expression level of IFN-γ. Results are shown as fold change compared with that in 
the non-infection group. (non-infection group–n=3; control group–n=8; cDC-
























Fig 8. T cell response of DT-injected BDCA2-DTR BMTed mice (pDC-ablated 
mice) upon H. felis infection (A) Gating strategy to identify pDCs from isolated 
cells of the entire glandular stomach upon H. felis infection (B) The percentage of 
pDCs in the live single cells of the spleen, gastric lymph node (LN), and stomach 
in the pDC-ablated mice (n=5) and PBS-injected BDCA2-DTR BMTed mice 
(control mice) (n=6) Representative FACS plot of four pooled stomachs per group 
(left panel). (C) The percentage of total, CD8+ and CD4+ T cells in the live single 
cells of the stomach in the pDC-ablated mice (n=5) and control mice (n=6) (*P < 
















Despite many previous studies, the role of DCs in Helicobacter-infected 
individuals remains unclear. The mouse models with DC deficiency enabled the 
identification of the effects of DC deficiency on immune responses to Helicobacter 
and progression of gastric lesions. Interestingly, this study suggested that gastric 
cDCs attenuate T cell accumulation during Helicobacter infection and thus appear 
to limit immunopathology for the host stomach.  
Compared to the DCs present in other organs, relatively little is known about 
gastric DC; thus, the characterization of gastric DCs was focused first. Gastric DCs 
were defined as CD64-CD11c+MHC IIhi population and gastric DCs were 
composed of CD103+, CD11b+, and DN subsets. Because macrophages can also 
express CD11c and MHC II to varying levels and might be contained in the CD11b+ 
subset, macrophages were excluded in advance by using CD64 and CD11b markers 
(Bain, Scott et al. 2013). The DCs and their subset populations adequately 
expressed transcription factors Zbtb46, IRF8, and IRF4 as well as the chemokine 
receptor XCR1 (Satpathy, KC et al. 2012; Mildner and Jung 2014), and were 
dependent on the Flt3–Flt3L pathway. Moreover, these populations were ablated 
by DT injection in Zbtb46-DTR mice. From these results, it was confirmed that the 
gastric CD64-CD11c+MHC IIhi population and its subsets are cDCs.  
Although the expression of the mature DC markers CD103 and CD11b was 
deficient in the DN subsets, they have been regarded as bona fide DCs, considering 
their similarity with the characteristics of mature DCs. Recent studies have shown 
that DN subsets are DC populations in an intermediate maturation stage, and reside 
in various organs, including the heart, lung, and liver (Clemente-Casares, 
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Hosseinzadeh et al. 2017). In this study, gastric DN subsets showed a two-peak 
pattern for the expression of IRF4, IRF8, and XCR1. These results seem to be 
similar to the findings of another study showing that DN subsets consist of two 
subtypes with the ability to mature into CD103+ and CD11b+ DCs (Clemente-
Casares, Hosseinzadeh et al. 2017). Thus, this study suggests that bona fide DN 
DCs are also present in the stomach.  
Conversely, a few CD103+CD11b+ cells were found in gastric DCs. One study 
considered CD103+CD11b+ cells to be one of the gastric DC subsets (Arnold, 
Zhang et al. 2017),; however, in this study, CD103+CD11b+ cells were not 
significantly depleted in the Flt3 KO and DT-treated Zbtb46-DTR BM transplanted 
mice. Although the CD103+CD11b+ DC subset has been identified in the intestine, 
further studies are needed on this population in the stomach. 
In this study, during Helicobacter infection, the infiltration of all gastric DC 
subsets was significantly increased, and T cells were accumulated in the stomach. 
Gastric lymph node was grossly enlarged in both WT and DC-deficient mice (Van 
den Broeck, Derore et al. 2006), and populations expressing the same surface 
markers as gastric DCs were found in the gastric lymph node. Considering that 
migration from a non-lymphoid organ to lymph node is a special ability of DCs 
(Worbs, Hammerschmidt et al. 2017), gastric DCs distributed in the superficial 
layer of the mucosal lamina propria seem to migrate to the gastric lymph node for 
T cell priming after recognizing and capturing Helicobacter antigens. However, 
these results show that the T cell priming process is sufficient with only a few 
gastric DCs and highlight that gastric DCs are committed to the role of peripheral 
T cell tolerance during Helicobacter infection. 
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When DCs are absent, CD8+ T cell infiltration increases extraordinarily in 
immune response to Helicobacter infection. Expression of anti-inflammatory 
cytokines: IL-10 and TGF-β did not changed, however, pro-inflammatory cytokines 
or chemokines like CCL2(MCP-1), CCL3(MIP-1α), CCL4(MIP-1β), 
CCL5(RANTES), and CCL8(MCP-2) were significantly upregulated in the 
stomach with gastritis. These pro-inflammatory chemokines would recruit CCR5-
expressing T cells to the stomach. Also, infiltrated CD8+ T cells appear to produce 
MIP-1α, MIP-1β, RANTES and MCP-1, which could result in consistent 
infiltration of T cells (Kim, Nottingham et al. 1998; Ohtani, Ohtani et al. 2004). 
These indicate gastric DCs suppress CD8+ T cells, which inhibit further T cell 
infiltration. Secretion of IFN-γ, Granzyme-A, and Perforin may be useful to 
eliminate Helicobacter, but eventually lead to deterioration of immunopathological 
damage (Sayi, Kohler et al. 2009). 
During Helicobacter infection, mucosal damage is accompanied by the loss of 
parietal cells and glandular structures (atrophy), SPEM, and further intestinal 
metaplasia when the lesion becomes more severe (Petersen, Mills et al. 2016). 
Mucosal epithelial metaplasia has been regarded as precancerous lesions because it 
is closely related to gastric cancer incidence in humans (Mera, Bravo et al. 2018). 
Interestingly, when DCs are absent, worsened oxyntic atrophy and mucous 
metaplasia were accompanied with an increase in T cell accumulation in the gastric 
mucosa. The gastric DCs may be involved in defense mechanism against 
carcinogenesis by slowing the progression of gastritis into gastric cancer. 
In conclusion, gastric DCs and DC subsets were finely characterized. It was 
also confirmed that gastric DCs are dependent on Flt3-Flt3L signaling and Zbtb46 
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and that gastric DCs are present in specific regions of the stomach, and they increase 
in number when gastritis is developed due to Helicobacter infection. In addition, it 
was determined that gastric DCs depress the infiltration of T cell into gastric 
mucosa, which results in protection against precancerous tissue damage. These 
findings contribute to a better understanding of the pathology of Helicobacter-








Programmed death ligand 1 expressing gastric classical dendritic 
cells attenuate Helicobacter-induced gastric inflammation via 




DCs play a crucial role in peripheral T cell tolerance as well as in inducing T 
cell immunity as immune regulator. Peripheral T cell tolerance by DCs in 
Helicobacter infection has been observed, and my previous in vivo studies 
supported this observation. Tregs induction, the secretion of anti-inflammatory 
cytokines and the expression of immune checkpoint molecules have been reported 
as the mechanisms by which DCs maintain peripheral T cell tolerance. In this study, 
one of the immune checkpoint molecules, PD-L1 was examined. A blockade of PD-
L1 enhanced gastritis with severe T cell accumulation during Helicobacter 
infection. In addition, gastric DCs expressed considerably higher level of PD-L1 
than other immune cells and co-localized with T cells in the stomachs of mice and 
humans. These findings suggest that gastric DCs attenuate Helicobacter-induced 













DCs have been recognized as typical immune cells that play a sentinel role in 
various organs, recognize invading pathogens, and induce a pathogen-specific 
acquired immune response. However, DCs are also imperative in inducing and 
maintaining central and peripheral immune tolerance (Steinman, Hawiger et al. 
2003; Thomson 2010), and these tolerogenic DCs are attracting attention as a 
potential type of immunotherapy to prevent autoimmune diseases and transplant 
rejection (Funes, Manrique de Lara et al. 2019). In general, tolerogenic DCs are 
immature or semi-mature, unlike immunogenic DCs that induce T cell activation, 
and the maturation state is determined by the expression level of MHC II, co-
stimulatory molecules CD80 and CD86, and the production of pro-inflammatory 
cytokines (Steinman, Hawiger et al. 2003; Funes, Manrique de Lara et al. 2019). 
DCs can inhibit effector T cells through a variety of pathways, such as the 
induction of Tregs, the production of anti-inflammatory cytokines, and the 
expression of immune checkpoint molecules. T cell inhibition by immune 
checkpoint molecules is mediated by the transfer of inhibitory signaling via 
inhibitory receptors expressed on T cells and the interruption of stimulatory T cell 
signaling (Arasanz, Gato-Cañas et al. 2017; Fife, Pauken et al. 2009). PD-1 and 
CTLA-4 are known to be typical inhibitory receptors of T cells (Cox, Nechanitzky 
et al. 2017), and DCs can bind to PD-1 and CTLA-4, respectively, by expressing 
the programmed death-ligands and B7-1 (CD80) and B7-2 (CD86).  
PD-1 is a member of the CD28 and CTLA-4 immunoglobulin superfamily and 
interacts with two B7 family ligands, PD-L1 (CD274) and PD-L2 (CD273) (Fife, 
Pauken et al. 2009). PD-L1 is known to be expressed in both hematopoietic and 
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non-hematopoietic cells in various organs, while PD-L2 is known to be expressed 
only in DCs and monocytes (Ishida, Iwai et al. 2002; Yamazaki, Akiba et al. 2002). 
PD-1 signaling modulates T cell-mediated immunity by regulating the number of T 
cells and their activities in multiple ways, such as inducing T cell exhaustion (Blank 
and Mackensen 2007; Day, Kaufmann et al. 2006; Sakuishi, Apetoh et al. 2010), 
anergy (Chikuma, Terawaki et al. 2009; Selenko-Gebauer, Majdic et al. 2003; 
Tsushima, Yao et al. 2007), and apoptosis (Chiu, Tsai et al. 2018; Dong, Strome et 
al. 2002; Petrovas, Casazza et al. 2006) and inhibiting T cell proliferation (Patsoukis, 
Sari et al. 2012). These effects of PD-1 signaling have been reported mainly in 
tumor, autoimmune, or viral infectious diseases, but they have recently been 
reported in bacterial infectious diseases (Jurado, Alvarez et al. 2008; Fankhauser 
and Starnbach 2014). 
In this study, the mechanism of the Tregs-independent T cell inhibition of 
gastric DCs in Helicobacter infection was examined. It was confirmed that gastric 
DCs strongly express PD-L1, not PD-L2, more than other immune cells and that 
the expression intensity increases with Helicobacter infection. In addition, PD-L1 
expressing gastric DCs were co-localized with T cells in the stomachs of mice and 
humans. It was also found that Helicobacter-induced T cell responses deteriorated 
when PD-1-PD-L1 signaling was deficient through PD-L1 antibody injection and 
the PD-L1 KO BM recipient mouse model. These findings indicate that gastric DCs 






Materials and Methods 
  
Mice 
Male C57BL/6J WT mice were purchased from the Japan SLC Inc. 
(Hamamatsu, Shizuoka, Japan) through the Central Lab. Animal Inc. (Seoul, Korea). 
All mice experiments were approved by the Animal Care and Use Committees of 
Seoul National University or Hanyang University (certification number: SNU-
140320-2-9, HY-IACUC-18-0048). 
 
Bone marrow transplantation 
BM cells from PD-L1 KO mice were injected intravenously into lethally 
irradiated (500 rad twice, 3 hours interval) WT C57BL/6 mice. BM transplanted 
mice were fed water containing 7.6% Baytril (Bayer Korea, Seoul, Korea) for 2 
weeks and monitored about, 6 weeks, until the transplanted BM is effectively 
reconstructed. 
 
PD-L1 in vivo blockade 
Anti-mouse PD-L1 (B7-H1) antibody (10F.9G2; Bio X Cell, West Lebanon, 
NH, USA) was intraperitoneally administered to H. felis-infected mice to block the 
PD-L1–PD-1 pathway during H. felis infection. 300 μg PD-L1 antibody diluted in 
InVivoPure pH 6.5 Dilution Buffer (Bio X Cell) was administered 6 times, once 
every 3 days, before necropsy. The rat IgG2b isotype control antibody (Bio X Cell) 




Helicobacter culture and Infection 
H. felis (ATCC 49179) was cultured in sterile-filtered brucella broth (Becton 
Dickinson, Sparks, MD, USA) containing 10% FBS. Mouse-adapted H. pylori SS1 
was cultured on brain heart infusion agar plates (Becton Dickinson) containing 10% 
sheep blood and H. pylori Selective Supplement (Thermo Fisher Scientific, 
Rockford, IL, USA). The brucella broth and brain heart infusion agar plates were 
maintained under microaerobic conditions produced using the GasPakTM EZ 
Campy Container System (Becton Dickinson) at 37°C. The brucella broth was 
maintained at 150 rpm shaking. After 24 hour fasting, 8-week-old mice were orally 
administered 0.2 ml suspension containing 2 × 108 H. felis or 1 × 109 colony-
forming unit/ml H. pylori 4 times every other day. 
 
Necropsy and Tissue preparation 
At 4 weeks after H. felis infection, each group of mice was sacrificed together 
with the non-infected control group, and stomach, gastric lymph node, and spleen 
were removed. The stomach was incised along the greater curvature and spread on 
a filter paper. After cutting the lesser curvature, half of the stomach was used for 
FACS and H. felis quantification. The lesser curvature portion of the other half was 
fixed in 10% neutral buffered formalin for histopathologic examinations, and the 
remaining was stored in a -70°C deep freezer for subsequent analysis. At 18 months 
after H. pylori infection, the H. pylori-infected groups were treated in the same 






Gastric tissues fixed in 10% neutral buffered formalin were cut into two strips. 
After standard tissue processing, gastric tissues were embedded in paraffin wax. 
Paraffin sections were stained with H&E and Alcian Blue (pH 2.5) stain kit (Vector 
Laboratories, Burlingame, CA, USA) and performed IHC for H+/K+-ATPase to 
assess histopathological changes. The degree of gastritis and pathological mucosal 
changes were assessed on the basis of previously established updated Sydney 
classification (Chen, van der Hulst et al. 1999; Sayi, Kohler et al. 2009). In the 
sections stained with Alcian blue, the amount of mucin in the gastric mucosa was 
measured using mean intensity in Image J software (National Institutes of Health, 
Bethesda, MD, USA). In the sections with IHC for H+/K+-ATPase, the number of 
positive cells was manually counted. The mucosa of two different areas was 
examined per slide at ×100 magnification, and the same anatomic areas were 
selected for each sample. 
 
Single-Cell Preparations and Flow Cytometric Analysis  
Gastric single cells were prepared to investigate the type of inflammatory cells 
that infiltrate into the stomach during Helicobacter infection. The gastric tissues 
were incubated in HBSS containing 2 mM EDTA (Cosmo Genetech, Seoul, Korea), 
2% FBS, and 1 mM DL-Dithiothreitol (Sigma-Aldrich, St. Louis, MO, USA) for 
15 min at 37°C with shaking. Then, the gastric tissue was finely trimmed and 
grinded using gentleMACSTM Dissociator (Miltenyi Biotec, Bergisch Gladbach, 
Germany) and incubated in HBSS containing 100 U/ml collagenase D (Roche, 
Mannheim, Germany), 10% FBS, and 10 mM HEPES for 30 min at 37°C with 
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shaking. After incubation, the gastric tissue was grinded once more using the 
gentleMACSTM Dissociator, filtered through a 70 μm cell strainer, and centrifuged 
to collect the separated single cells. Finally, the single cells were prepared by 
combining the cells collected from the suspension and from the gastric tissue. The 
gastric lymph node and spleen were incubated with 400 U/ml collagenase D at 37°C 
for 20 min to obtain separated single cells. The prepared single cells were primarily 
stained with Zombie Aqua (BioLegend, San Diego, CA, USA) to discriminate dead 
cells as per manufacturer’s protocol. Zombie aqua stained cells were then processed 
for Fc receptor block by using TruStain FcX antibody (anti-CD16/32, clone 93, 
BioLegend), to avoid non-specific binding. After the Fc receptors block, cells were 
incubated with a mixture of fluorochrome-labelled antibodies at 4°C for 30 min. To 
stain transcription factors (Foxp3), cells were fixed and permeabilized with 
Foxp3/Transcription Factor Staining Buffer Set (Thermo Fisher Scientific), as per 
manufacturer’s protocol, and then stained with antibody against each transcription 
factor. After washing briefly with RPMI 1640 medium with 10% FBS, cells were 
analyzed using BD LSRFortessa (BD Biosciences, San Jose, CA, USA) and FlowJo 
software (version 9.9 and 10.4; developed by FlowJo, LLC). 
 
Antibodies for flow cytometry 
The antibodies used for FACS are listed in Table 1. 
Table 1. List of antibodies 
Antibody Clone Catalog No. Source 
CD103 2E7 11-1031-81 eBioscience 
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Foxp3 FJK-16s 17-5773-82 eBioscience 
CD40 1C10 17-0401-81 eBioscience 
CD4 GK1.5 553730 
BD 
Bioscience 
PD-L2 TY25 564245 
BD 
Bioscience 




101206, 101216, 101212, 
101226 
BioLegend 
CD64 X54-5/7.1 139304, 149320 BioLegend 
MHC II M5/114.15.2 107621, 107628 BioLegend 
Ly6C HK1.4 128006 BioLegend 
CD45 30-F11 103130 BioLegend 
CD11c N418 117318 BioLegend 
NK1.1 PK136 108714 BioLegend 
CD8α 53-6.7 100762 BioLegend 
F4/80 BM8 123146 BioLegend 
PD-L1 10F.9G2 124315 BioLegend 
CD86 GL-1 105012 BioLegend 
CD19 6D5 115527 BioLegend 
B220 RA3-6B2 103223 BioLegend 
CD3 17A2 100228 BioLegend 
Ly6G 1A8 127641 BioLegend 
CD80 16-10A1 104725 BioLegend 
Rat IgG2α, κ 
Isotype 
RTK2758 








Immunohistochemistry and Immunofluorescence 
After paraffin-embedded sections were dewaxed and hydrated, antigen 
retrieval was performed using citrate buffer (pH 6.0; Sigma-Aldrich). Next, the 
sections were incubated with 0.3% hydrogen peroxide solution for 30 min to block 
endogenous peroxidase activity. The ImmPRESS Peroxidase Polymer kit (Vector 
Laboratories) was used according to manufacturer’s protocol. Briefly, paraffin-
embedded sections were blocked with 2.5% normal horse serum or 2.5% normal 
goat serum for 1 hour and then incubated with the following primary antibodies at 
4°C overnight or at 20°C for 2 hours: rabbit anti-CD3 (1:200; Dako, Glostrup, 
Denmark), mouse anti-ATPase (1:4000; MBL, Woburn, MA, USA), rat anti-CD8α 
(1:200; Novus, Centennial, CO, USA), and rabbit anti-PD-1 (1:100; Cell Signaling 
Technology). The paraffin-embedded sections were washed with PBS and then 
incubated with appropriate horseradish peroxidase-conjugated secondary antibody 
(Vector Laboratories) for 1 hour. ImmPACT DAB substrate (Vector Laboratories) 
was used for chromogenic detection. The sections were counterstained with 
hematoxylin. The immunofluorescence was detected using Alexa594-conjugated 
goat anti-rat IgG (Jackson ImmunoResearch, West Grove, PA, USA) and Alexa488-
conjugated goat anti-rabbit IgG (Invitrogen, Carlsbad, CA, USA) at 1:400. The 
sections were counterstained with DAPI (Thermo Fisher Scientific) and mounted 
using mounting medium (Vector Laboratories). In anti-ATPase IHC, Mouse on 
Mouse ImmPRESS Peroxidase Polymer Kit (Vector Laboratories) was used to 
block endogenous mouse immunoglobulin.  
For frozen sections, after blocking with 2.5% normal goat serum (Vector 
Laboratories) for 1 hour and following primary antibodies were used for overnight 
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incubation at 4°C: rat anti-CD45 (1:100; Abcam, Cambridge, UK), rabbit anti-PD-
L1 (1:100; Invitrogen), Armenian hamster anti-CD11c (1:100; BD Biosciences), 
and rat anti-CD8α (1:100; Novus, Centennial, CO, USA). Immunofluorescence was 
detected using Alexa594-conjugated goat anti-rat IgG (Jackson ImmunoResearch), 
Alexa594-conjugated goat anti-rabbit IgG (Invitrogen), Alexa488-conjugated goat 
anti-rabbit IgG (Invitrogen) and Alexa488-conjugated goat anti-Armenian hamster 
IgG (Jackson ImmunoResearch) at 1:400. The sections were counterstained with 
DAPI and mounted using mounting medium (Vector Laboratories). The images 
were obtained using confocal fluorescence microscope (Eclipse TE200; Nikon, 
Japan).  
 
H. felis Quantification 
Total DNA was extracted from the gastric tissues (corpus and antrum) by using 
QIAamp DNA mini kit (Qiagen, Hilden, Germany) and used to identify H. felis 
DNA. qRT-PCR was performed using specific primers for H. felis flagellar filament 
B (Fla-B), Rotor-Gene SYBR Green PCR kit, and Rotor-Gene Q (Qiagen). The 
amplified target DNA was analyzed using Rotor-Gene Q series software. The H. 
felis Fla-B primer–F: 5′-TTC GAT TGG TCC TAC AGG CTC AGA-3′ and R: 5′-
TTC TTG TTG ATG ACA TTG ACC AAC GCA-3′– was used (El-Zaatari M, Kao 
et al. 2013). 
 
Quatitative Reverse Transcription-PCR 
Total RNA from gastric tissues was extracted using Hybrid-R RNA 
purification kit (GeneAll, Seoul, Korea). The cDNA was synthesized from 0.1 μg 
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of RNA by using QuantiTect Reverse Transcription kit (Qiagen). qRT-PCR was 
performed using specific primers, Rotor-Gene SYBR Green PCR kit, and Rotor-
Gene Q (Qiagen). The amplified target cDNA was analyzed using Rotor-Gene Q 
series software against the housekeeping gene GAPDH. The specific primer pairs 
were F: 5′-TGC ACC ACC AAC TGC TTA G-3′ and R: 5′-GGA TGC AGG GAT 
GAT GTT C-3′ for mouse GAPDH; F: 5′-AGC GGC TGA CTG AAC TCA GAT 
TGT AG-3′ and R: 5′-GTC ACA GTT TTC AGC TGT ATA GGG-3′ for mouse IFN-
γ; and F: 5′-TGG ACA AAC AGT GAC CAC CAA-3′ and R: 5′-CCC CTC TGT 
CCG GGA AGT-3′ for mouse PD-L1. 
 
Tissue-microarrayed human gastric tissue and multiplexed 
immunohistochemistry  
Formalin-fixed paraffin-embedded tissue samples of surgically resected 
human gastric tissue were retrieved from the archives of Department of Pathology, 
Seoul National University Bundang Hospital. The collected tissue samples were 
remaining samples after proper histologic diagnosis and relevant molecular study. 
Representative tissue area were reviewed and selected for the construction of tissue 
microarray. 
In this study, formalin-fixed paraffin-embedded gastric tissue samples of 20 H. 
pylori-negative patients, 31 H. pylori-positive patients, and 46 patients with 
mucosal dysplasia were analyzed. Each tissue sample was 1–2 mm in diameter. 
Multiplexed IHC was performed sequentially on each single slide in the order of 
PD-L1, CD11c, and CD3 by using Autostainer Link48 (Dako) as previously 
described (Koh, Kwak et al. 2019). The primary antibodies used were as follows: 
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rabbit anti-PD-L1 (1:30; Cell Signaling Technology), rabbit anti-CD11c (1:100; 
Abcam), and rabbit anti-CD3 (1:300; Dako). After the immunostained sections 
were scanned using the Aperio AT2 (Leica Biosystems, Newcastle, UK), the slides 
were incubated in pre-mixed stripping buffer for antibody stripping. The slides were 
microwaved at low power to obtain more effective stripping, followed by 
immunostaining for next primary antibody. 
The study was approved by the Institutional Review Board (IRB) of Seoul 
National University Bundang Hospital (IRB number: B-1606/349-308) and Seoul 
National University Hospital (IRB number: 1706-105-860) and performed in 




All data are shown as means ± standard errors. Statistical analysis was 
performed using GraphPad Prism 7.00 (GraphPad Software, San Diego, CA, USA). 
Two groups were compared using Mann-Whitney U test or unpaired t-test with two-
tailed distributions. When three or more groups were included, the results were 
analyzed using Kruskal-Wallis test or ordinary one-way ANOVA followed by 
Mann-Whitney U test or unpaired t-test with two-tailed distributions. Two-tailed P 






Gastric cDCs expressed high level of PD-L1 and co-localized with T cells in 
Helicobacter-infected gastric mucosa and submucosa  
To elucidate the cause of severe T cell accumulation in DC-deficient mice 
during Helicobacter infection, the mechanisms of T cell inhibition of DCs were 
examined. DCs can inhibit T cells via immune tolerance mechanisms such as 
induction of Tregs, production of anti-inflammatory cytokines, and expression of 
immune checkpoint molecules (Sharpe, Wherry et al. 2007; Darrasse-Jèze, 
Deroubaix et al. 2009; Schülke 2018). In my previous study, cDC depletion did not 
affect Treg infiltration and IL-10 and TGF-β mRNA expression. Therefore, in this 
study, the expression of immune checkpoint molecules on gastric DCs was focused 
and the expression level of PD-L1, PD-L2, and T cell co-stimulatory molecules, 
including CD80, CD86, and CD40 were examined. Regardless of H. felis infection, 
all gastric DC subsets expressed higher level of PD-L1 than other gastric immune 
cells, including macrophages and neutrophils. PD-L1 expression of DCs was 
increased by H. felis infection, whereas that of macrophages and neutrophils 
remained similar regardless of H. felis infection (Fig 1A). The gastric DCs also 
expressed higher level of PD-L1 than splenic DCs (Fig 1B). H. pylori infection 
increased PD-L1 expression on gastric DCs, which was also significantly higher 
than that of other immune cells. In particular, PD-L1 expression on CD11b+ DC 
subset was markedly increased by H. pylori infection (Fig 1C). Helicobacter 
infection did not affect the expression of PD-L2, CD80, and CD40, but increased 
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the expression of CD86 on cDCs (Fig 1D and 1E). Furthermore, PD-L1 mRNA 
expression was decreased in Flt3 KO mice during H. felis infection (Fig 1F).  
Immunofluorescence staining for PD-L1, CD45, CD11c, CD8α, and PD-1 in 
the gastric tissue revealed that PD-L1+ cells were mainly located in the submucosa 
and mucosal laminar propria right above the muscularis mucosa. However, the 
mucosal epithelial cells showed scant PD-L1 expression (Fig 2A and 2B). The 
majority of PD-L1+ cells were co-stained with CD45 antibody (Fig 2A), and these 
CD45+PD-L1+ cells were in contact with CD8α+ cells (Fig 2B). In addition, CD11c+ 
cells expressed PD-L1, and the majority of CD8α+ cells co-expressed PD-1 (Fig 
2C). These results indicate that PD-L1-expressing gastric DCs interacted with PD-






































Fig 1. High level of PD-L1 expression of gastric DCs and location of PD-L1 
expressing gastric DCs in the stomach during Helicobacter infection (A) PD-L1 
expression on innate immune cells against H. felis infection. Note that DCs and DC 
subsets express considerably higher level of PD-L1 than other cell types. Each 
figure is representative of two experiments. Three mice per group were pooled for 
each experiment. (B) Comparison of PD-L1 expression level in gastric DCs and 
splenic DCs during H. felis infection. Left figure is representative of at least three 
experiments. Three mice per group were pooled for each experiment. The stomach 
and spleen were collected from the same individuals. (C) As in (A), but with H. 
pylori infection. Note that DCs and DC subsets express considerably higher level 
of PD-L1 than other cell types. (D) Expression level of PD-L2, CD80, CD86, and 
CD40 on innate immune cells against H. felis infection. Each figure is 
representative of two experiments. Three mice per group were pooled for each 
experiment. (E) Expression level of PD-L2 on innate immune cells against H. pylori 
infection. Three mice per group were pooled for the experiment. The number in the 
histogram means the median fluorescence intensity (MFI) value. The MFI value 
was calculated by subtracting the MFI value of the isotype control corresponding 
to each population. (F) Relative PD-L1 mRNA expression level of Flt3 KO and WT 
mice after H. felis infection for 8 weeks. Results are shown as fold change compared 
with non-infection group (non-infection group–n=2; H. felis infection group–n=7) 
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Fig 2. (A and B) Immunofluorescence for PD-L1, CD45, and CD8α on H. felis-
infected WT mice stomach. Note the localization of PD-L1+ cells (submucosa and 
mucosal laminar propria right above the muscularis mucosa). PD-L1+ cells are co-
stained with CD45 and co-localize with CD8+ T cells. (Mu: mucosa, S.M: 
submucosa, M.E: muscularis externa, and Se: serosa) (C) PD-L1+CD11c+ DCs 















Blockade of PD-L1 enhanced the gastric inflammation with severe T cell 
accumulation upon Helicobacter infection 
To confirm the role of PD-L1 in the host immune response to Helicobacter 
infection, PD-L1 antibodies (Ab) were injected into H. felis-infected WT mice to 
block PD-L1 signals. Next, gastric lesions were analyzed at 4 weeks after infection. 
Histologically, lymphocyte infiltration into the gastric submucosa and mucosal 
lamina propria and pathological mucosal changes were markedly more severe in 
the PD-L1 Ab injection group than in the isotype Ab injection group (Fig 3A). 
Furthermore, T cell infiltration into the mucosal lamina propria was prominent in 
the PD-L1 Ab injection group (Fig 3B). The infiltration of CD8+ and CD4+ T cells 
was more prominent in the PD-L1 Ab injection group than in the isotype Ab 












































































Fig 3. Deterioration of H. felis-induced gastric lesions and prominent T cell 
response in mice with PD-L1 blockade by using PD-L1 antibody injection after H. 
felis infection for 4 weeks. (A) Histopathological analysis of H. felis-induced 
gastritis, oxyntic atrophy, and mucous metaplasia according to grading standards 
on H&E stain. H&E stained representative images of isotype control mice (left 
panel) and mice with PD-L1 blockade (right panel). Bottom left: Inflammation 
score, Bottom right: Mucosal change score (isotype control mice–n=9; PD-L1 
blockade mice–n=9) (B) More severe mucosal infiltration of T cells in the stomach 
of mice with PD-L1 blockade. Representative images of CD3 IHC (DAB). (C) The 
percentage of CD8+ and CD4+ T cells and Tregs in the live single cells of the 
stomach in the mice with PD-L1 blockade (n=9) and isotype control mice (n=9). 
Representative FACS plots (top panel) (*P < 0.05) 
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PD-L1 deficiency in BM-derived cells enhanced gastric inflammation upon 
Helicobacter infection 
PD-L1 has been known to be expressed in not only various hematopoietic cells 
but also non-hematopoietic cells such as muscle cells, mucosal epithelial cells, and 
vascular endothelial cells (Sharpe, Wherry et al. 2007). Several studies have shown 
that PD-L1 expressed on the mucosal epithelial cells was increased in response to 
H. pylori infection, which plays an important role in suppressing T cell responses 
in the stomach (Das, Suarez et al. 2006; Holokai, Chakrabarti et al. 2019). To 
analyze the influence of PD-L1 on BM-derived cells in Helicobacter infection, BM 
chimeras were created by transplantation of PD-L1 KO or WT BM into irradiated 
WT mice. The H. felis-infected recipient mice were analyzed after 4 weeks. 
Histologically, the inflammatory lesions and pathological mucosal changes were 
more prominent in the PD-L1 KO BM transplanted mice than in the WT BM 
transplanted mice (Fig 4A, 4B, and 4C). FACS analysis of gastric tissues showed 
that both CD8+ and CD4+ T cell responses were markedly prominent in PD-L1 KO 
BM transplanted mice than in WT BM transplanted mice, and Treg infiltration was 
further increased in the PD-L1 KO BM transplanted mice (Fig 4D). The bacterial 
load in the stomach was lower in PD-L1 KO BM transplanted mice than in WT BM 
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Fig 4.  Deterioration of H. felis-induced gastric lesions and prominent T cell 
response in PD-L1 KO BMTed mice after H. felis infection for 4 weeks (A) 
Histopathological analysis of H. felis-induced gastritis. H&E stained representative 
images of WT BMTed (left panel) and PD-L1 KO BMTed (right panel) mice. (B) 
Histopathological analysis of H. felis-induced oxyntic atrophy and mucous 
metaplasia. Representative serial images of WT BMTed (left panel) and PD-L1 KO 
BMTed (right panel) mice subjected to  Alcian blue staining (top) and H+/K+-
ATPase IHC (bottom). (C) Left: Inflammation score, Middle: Mean intensity of 
mucosal Alcian blue positive, Right: Manual cell count number of H+/K+-ATPase+ 
cells (parietal cells) (WT BMTed–n=11; PD-L1 KO BMTed–n=11) (D) The 
percentage of CD8+ and CD4+ T cells and Tregs in the live single cells of the 
stomach in the WT BMTed (n=11) and PD-L1 KO BMTed (n=11) mice. 
Representative FACS plots (top panel) (E) H. felis loads were evaluated using qRT-
PCR for H. felis Fla-B DNA extracted from gastric tissues (WT BMTed–n=11, PD-





PD-L1 expressing DCs co-localized with T cells in human Helicobacter-positive 
gastritis 
To determine whether PD-L1-expressing DCs co-localize with T cells in the 
gastric mucosa of H. pylori-infected patients, multiplexed IHC for CD11c, PD-L1, 
and CD3 was performed. CD11c+ cells were distributed in the mucosal lamina 
propria and submucosa, and their numbers were significantly higher in the stomach 
of H. pylori-positive patients and patients with mucosal dysplasia than in H. pylori-
negative patients. PD-L1 expression was mostly found in infiltrated cells not in 
epithelial cells. Importantly, the CD11c+PDL1+ cells were in contact with CD3+ 
cells in the gastric mucosa (Fig 5A and 5B). The CD11c+PDL1+ cells were higher 
in the gastric mucosa of H. pylori-positive patients than in H. pylori-negative 
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Fig 5. Co-localization of PD-L1+CD11c+ DCs and CD3+ T cells in the human 
stomach. (A) Multiplexed IHC-stained representative images of the stomach of H. 
pylori-positive patients (left panel) and patients with mucosal dysplasia (right 
panel). All images immunostained on the gastric tissue from each patient came from 
the same paraffin section. Note that PD-L1+CD11c+ cells (arrows) co-localize with 
CD3+ cells. (B) Multiplexed IHC stained representative images of the stomach of 
other H. pylori-positive patients. Note that the positions of PD-L1+ and CD11c+ 
cells are similar (low-power fields) and PD-L1+CD11c+ cells (arrows) co-localize 
with CD3+ cells (high-power fields) (B) Manual cell count number of PD-
L1+CD11c+ cells in a section of a biopsy sample (H. pylori-negative sample–n=21; 













































Despite many previous studies, the role of DCs in Helicobacter-infected 
individuals remains unclear. In my previous study, it was found that gastric DCs 
attenuated Helicobacter-induced gastric lesions by inhibiting T cells. Considering 
that no significant changes in the Tregs response were observed in DCs deficient 
mice, immune checkpoint molecules were noted as the mechanism of the T cell 
suppression of gastric DCs. Interestingly, gastric DCs expressed PD-L1 much more 
strongly than other immune cells, and the location of PD-L1+ cells in the stomach 
was similar to that of gastric DCs. PD-L1+CD11c+ cells, which are presumed to be 
PD-L1 expressing gastric DCs, co-localized with T cells. In addition, the 
Helicobacter-induced immune responses of mouse model with the PD-L1 signal 
blocked were similar to those of DC-deficient mice. Given these results, gastric 
DCs appear to suppress Helicobacter-induced T cells and to attenuate the 
pathological progression of gastric lesions by expressing PD-L1. 
In general, the mechanisms of immune modulation by DCs are thought to be 
based on the interaction between DCs and Tregs, in other word, Treg-mediated 
(Kornete and Piccirillo 2012). Nonetheless, in this study, neither Treg number and 
percentage nor TGF-β expression was different between WT and the DC-ablated 
group. This indicates that gastric DCs perform immune modulatory functions via a 
Treg-independent mechanism. 
One of the Treg-bypassing immune modulatory mechanisms of DCs is 
activating the immune checkpoint pathway of T cells. Immune checkpoint 
molecules, also known as co-inhibitory molecules, include PD-1 and cytotoxic T 
lymphocyte-associated antigen 4, which are expressed on T cells; they are known 
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to offset against T cell co-stimulation by B7 molecules–CD28 interaction. PD-1 has 
two ligands: PD-L1 and PD-L2, which are expressed on antigen-presenting cells 
such as macrophages and DCs. Thus, the expression of PD-1 ligands on DCs can 
regulate T-cell mediated immune responses through a non-Treg-associated manner. 
These results suggest that the modulation of T cell-mediated immune response via 
PD-L1–PD-1 signaling by DCs indeed occurs during gastritis in situ. 
PD-L1–PD-1 signaling modulates T cell-mediated immunity by regulating the 
number of T cells and their activity, through multiple ways, for instance, by 
inducing T cell exhaustion (Wherry 2011), anergy (Chikuma, Terawaki et al. 2009), 
and apoptosis (Dong, Strome et al. 2002) and by inhibiting T cell proliferation 
(Patsoukis, Sari et al. 2012). These effects of PD-L1–PD-1 signaling have been 
reported mainly in tumors and autoimmune or viral infectious diseases, but have 
also been reported in bacterial infectious diseases (Jurado, Alvarez et al. 2008). 
Inhibition of the host immune response by PD-L1–PD-1 signaling is vulnerable to 
the control of infectious agents and leads to chronic infection while reducing host 
tissue damage due to aggressive T cell responses (Sharpe, Wherry et al. 2007). 
Similarly, in Helicobacter infection, when PD-L1 was blocked or depleted on 
leukocytes, the phenotype similar to that noted in the absence of DCs was observed: 
worsened gastritis and pathological mucosal changes as well as increment in the 
number of T cells. These findings indicate that the impairment of DCs is related 
with a shortage of PD-L1 level in the stomach, which causes the loss of T cell 
regulation. 
Some studies showed that the gastric epithelium expresses PD-L1. These 
studies were performed using gastric epithelial cell lines (Das, Suarez et al. 2006) 
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or gastric organoid culture differentiated from human-induced pluripotent stem 
cells (Holokai, Chakrabarti et al. 2019); thus, they might have not focused on 
whether PD-L1 is expressed on leukocytes. In this study, PD-L1 expression on DCs 
was observed by FACS of isolated single cells from the whole stomach and by IHC 
on tissue sections completely representing the histological structure of the stomach. 
Therefore, the difference in PD-L1 expression between leukocytes and non-
leukocytes, including gastric epithelial cells, could be identified. And it was found 
that gastric DCs express considerably higher PD-L1 than gastric epithelial cells. 
As mentioned above, PD-L1+ gastric DCs were located primarily in the 
submucosa and mucosal laminar propria right above the muscularis mucosa with T 
cells. These DCs are considered as a cellular barrier, protecting the gastric mucosa 
from the infiltration of T cells. Without these barrier-functioning DCs, T cells may 
remarkably infiltrate into the gastric mucosa to kill Helicobacter, but inadvertently 
cause severe damage to the mucosa. During Helicobacter infection, mucosal 
damage is accompanied by the loss of parietal cells and glandular structures 
(atrophy), SPEM, and further intestinal metaplasia when the lesion becomes more 
severe (Petersen, Mills et al. 2016). Mucosal epithelial metaplasia has been 
regarded as precancerous lesions because it is closely related to gastric cancer 
incidence in humans (Mera, Bravo et al. 2018). Interestingly, when DCs are absent, 
worsened oxyntic atrophy and mucous metaplasia were accompanied with an 
increase in T cell accumulation in the gastric mucosa. The gastric DCs may be 
involved in defense mechanism against carcinogenesis by slowing the progression 
of gastritis into gastric cancer. However, considering that a recent study showed that 
immune stromal PD-L1 expression is associated with poor prognosis in patients 
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with gastric adenocarcinoma (Thompson, Zahurak et al. 2017), and the result of this 
study that PD-L1+ gastric DCs still co-localize with T cells in some patients with 
mucosal dysplasia, the suppression of T cells by gastric DCs through PD-L1 
expression might have a deleterious or beneficial effect on the host depending on 
the pathological progression of gastric lesions. 
Along with other immune checkpoint inhibitors, PD-1 and PD-L1 inhibitors 
are recently highlighted as novel concepts of anti-cancer therapy. Some of them 
have received Food and Drug Administration approval and have shown 
effectiveness, thereby increasing expectations. However, these inhibitors are 
reported to have inflammatory side-effects called immune-related adverse events 
(IRAEs), and stomach is a one of the most IRAE-prone organs (Lu, Firpi-Morell et 
al. 2018; Postow, Sidlow et al. 2018; Samaan, Pavlidis et al. 2018). Thus, 
considering the possibility of IRAE occurrence in the stomach would be important 
when treating cancer patients with checkpoint inhibitors. The inflammatory events 
revealed in this study might provide a basis to elucidate the mechanism of IRAE 
occurrence in the stomach. 
In conclusion, it was found that gastric DCs perform immune modulatory 
functions in a Treg-independent manner via the PD-L1–PD-1 pathway, which 
protects against precancerous mucosal damage. This study shows that DCs are 
important in preventing the progression of gastritis into a more severe form and 








DCs have been reported to play an important role in controlling the immune 
response to Helicobacter infection, which is highly correlated with chronic gastritis 
and gastric cancer in humans. To determine the role of DCs in Helicobacter 
infection, many previous studies have focused on the response of human moDCs or 
mouse BM-derived DCs to Helicobacter in vitro. However, in vivo experiments and 
characterization of gastric DCs are essential to clarify the role of DCs in 
Helicobacter-infected gastric tissues, but little is known about them. This study was 
carried out in order to contribute to the knowledge of these deficiencies.  
In this study, the DC-deficient mouse models and the PD-L1-deficient mouse 
models have enabled the identification of the role of gastric cDCs on immune 
responses to Helicobacter and progression of gastric lesions. Gastric cDCs was 
defined as CD64-CD11c+MHC IIhi population and identified that gastric DCs are 
composed of CD103+, CD11b+, and DN subsets. In normal stomach, gastric cDCs 
were located mainly in the superficial mucosal lamina propria. However, when 
gastritis was induced by Helicobacter infection, the number of gastric cDCs rapidly 
increased, and gastric cDCs migrated around muscularis mucosa and submucosa 
where numerous T cells were present. These gastric cDCs deficiency worsened 
gastritis with significant T cell infiltration and pathological mucosal changes 
considered a precancerous lesion during Helicobacter infection. Gastric cDCs 
expressed considerably higher level of PD-L1 than other immune cells and co-
localized with T cells in mouse and human stomach. In addition, blockade of PD-
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L1 exacerbated gastritis with severe T cell accumulation during Helicobacter 
infection. 
In conclusion, gastric cDCs are considered as a cellular barrier, protecting the 
gastric mucosa from the infiltration of T cells by expressing PD-L1. Without these 
barrier-functioning gastric cDCs, T cells may remarkably infiltrate into the gastric 
mucosa to kill Helicobacter, but inadvertently cause severe damage to the mucosa. 
This study is the first report that gastric cDCs perform immune modulatory 
functions in the stomach via the PD-L1-PD-1 pathway. In addition, this study shows 
the possibility of this phenomenon occurring in human gastric tissues and 
contributes to a better understanding of the pathology of Helicobacter-induced 
gastritis. Furthermore, this study suggests the mechanism of IRAEs occurring in the 
stomach by the use of PD-1 and PD-L1 inhibitors, which have recently been 
highlighted as anti-cancer theraphy. 
I believe that this study will be of great help in future researches of gastric DCs 
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Helicobacter 감염에 의한 위염에서  
위 점막 수지상세포의 역할  
 
고 두 민 
 




서울대학교 대학원 수의학과 수의병리학 전공 
 
수지상세포는 여러 장기에 존재하는 중요한 면역조절세포로 알려져 
있지만, 위 조직 내에 존재하는 수지상세포에 대해서는 알려진 바가 거의 
없다. 또한 수지상세포는 Helicobacter 감염에서 숙주의 면역 반응을 
조절하는데 중요한 역할을 하는 것으로 보고되어왔으나 위 조직 내에서의 
역할은 아직 명확하지 않다. 본 연구는 위 조직 내 수지상세포의 표현형을 
조사하고 Helicobacter 에 의해 유발된 위염에서 이들의 역할을 규명하기 
위하여 수행되었다.  
본 연구는, Helicobacter 에 감염된 수지상세포 결핍 마우스 모델과 각 
대조군 마우스의 위 조직을 병리조직학적 분석, 유세포 분석, 면역 조직 화학 
염색 및 면역 형광 염색, 실시간 중합효소연쇄반응 및 Luminex 면역 
분석법으로 비교 분석하였다. 또한, PD-L1 결핍 마우스 모델을 이용하여 
수지상세포의 T 세포 조절 기전을 확인하였고, 다중면역조직화학 염색을 
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이용하여 사람의 위 조직내에서 PD-L1 을 발현하는 수지상세포와 T 세포의 
위치적인 연관성을 확인하였다.  
위 점막 수지상세포는 CD103+CD11b-, CD103-CD11b+ 및 CD103-
CD11b- 의 표현형을 발현하는 아형들로 구성되어있었으며 정상 위 
조직에서는 점막층에 소수 존재하고 있었다. Helicobacter 감염 시, 모든 
수지상세포 아형들은 수적으로 증가하였고, 이러한 위 수지상세포들은 
염증세포 침윤이 현저한 점막하조직 주변에서 주로 관찰되었다. 수지상세포 
결핍 마우스에서는 대조군 마우스에 비하여 현저한 T 세포 침윤을 동반한 
심한 위염과 위 점막의 병리학적 변화가 관찰되었다. 수지상세포 결핍 시 
관찰된 위 병변의 악화는 Helicobacter 감염에서 수지상세포의 염증 억제 
역할을 시사한다. 
Helicobacter 감염 시, 수지상세포의 결핍은 regulatory T 세포의 침윤 
정도에 영향을 주지 않았다. 위 점막 수지상세포는 다른 면역 세포들보다 
상당히 높은 수준의 PD-L1 을 발현하고 있었으며, 마우스와 사람의 위 조직 
내에서 T 세포와 위치적으로 공존하고 있었다. 또한, Helicobacter 에 감염된 
PD-L1 결핍 마우스와 수지상세포 결핍 마우스의 위 조직 병변의 양상은 
매우 유사하였다.  
위의 결과들을 종합해 볼 때, 수지상세포들은 위 조직 내에서 PD-L1 
발현을 통해 T 세포 침윤을 직접적으로 억제함으로써 Helicobacter 감염에 
의하여 유발되는 위염을 약화시키는 것으로 보인다. 본 연구는 위 점막 
수지상세포의 역할과 Helicobacter 감염에 의하여 위 조직 내에서 일어나는 
면역반응에 대한 새로운 지견을 제공함과 더불어 임상적으로 위 조직 내에서 




핵심어: 수지상세포, 위염, Helicobacter, programmed death ligand 1 (PD-
L1), programmed death 1 (PD-1), T 세포  
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